<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        11-548-23
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ALPHAGAN-P 0.15% OPHTHALMIC SOLUTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BRIMONIDINE TARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.15
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Ophthalmic solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        38.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALLERGAN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALLERGAN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AbbVie Inc
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01EA05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ALPHAGAN&reg; P is used to reduce high pressure in the eye in patients with open angle glaucoma or ocular hypertension.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not use ALPHAGAN&reg; P</strong><br />&bull; If you are allergic (hypersensitive) to brimonidine tartrate or any of the other ingredients of ALPHAGAN&reg; P. See section 6-Further information at the end of this<br />leaflet for a full list of ingredients.<br />&bull; If you are taking monoamine oxidase (MAO) inhibitors or certain antidepressants. You must inform your doctor if you are taking any antidepressant drug.<br />&bull; If you are breast-feeding.<br />&bull; in children under the age of 2 years.</p><p><br /><strong>b. Take special care with ALPHAGAN&reg; P</strong><br />Before you take this medicine, tell your doctor:<br />&bull; If you suffer or have suffered from depression, reduced mental capacity, reduced blood supply to the brain, heart problems, a disturbed blood supply of the limbs or<br />a blood pressure disorder.<br />&bull; If you have or have had in the past kidney or liver problems.<br />&bull; If being given to a child between the age of 2 and 12 years because Alphagan P is not recommended for use in this age group.<br />Avoid touching the dropper tip against your eye or anything else. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions. Always replace the cap after using. If the solution changes colour or becomes cloudy, do not use. Do not use<br />the product after the expiration date marked on the bottle.<br />If you have ocular surgery or develop an intercurrent ocular condition (e.g., trauma or infection), you should immediately seek your doctor&rsquo;s advice concerning the continued use of the present multidose container.</p><p><br /><strong>c. ALPHAGAN&reg; P with other medicines, herbal or dietary supplements:</strong><br />Please tell your doctor, health care provider or pharmacist if you are taking or have recently taken any other medicine, including medicines obtained without a prescription</p><p>.<br /><strong>DRUG INTERACTIONS:</strong><br />Tell your doctor if you are taking any of the following medicines:<br />&bull; pain killers, sedatives, opiates, barbiturates or are regularly consuming alcohol.<br />&bull; anaesthetics.<br />&bull; to treat a heart condition or to lower blood pressure.<br />&bull; that can affect the metabolism like chlorpromazine, methylphenidate and reserpine.<br />&bull; which work on the same receptor as Alphagan&reg; P, for example isoprenaline and prazosin.<br />&bull; monoamine oxidase (MAO) inhibitors and other antidepressants.<br />&bull; medicines for any condition, even if unrelated to your eye condition.<br />&bull; or if the dose of any of your current medicines is changed.<br />These could affect your treatment with Alphagan&reg; P</p><p><br /><strong>d. Using ALPHAGAN&reg; P with food and drink</strong><br />ALPHAGAN&reg; P is not expected to interact with food and drinks.<br />e. Pregnancy and breast-feeding:<br />Pregnancy Category B: Teratogenicity studies have been performed in animals. Brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. The highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved AUC exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with ALPHAGAN&reg; P 0.15%,1 drop in both eyes three times daily.<br />There are no adequate and well-controlled studies in pregnant women; however, in animal studies, brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. Because animal reproduction studies are not always predictive of human response, ALPHAGAN&reg; P should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.</p><p>Nursing Mothers: It is not known whether brimonidine tartrate is excreted in human milk, although in animal studies, brimonidine tartrate has been shown to be excreted in breast milk. Because of the potential for serious adverse reactions from ALPHAGAN&reg; P in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.<br />Ask your doctor or pharmacist for advice before taking any medicine. Tell your doctor if you are pregnant or planning to become pregnant.<br />f. Driving and using machines<br />&bull; Alphagan&reg; P may cause blurred or abnormal vision. This effect may seem worse at night or inreduced lighting.<br />&bull; Alphagan&reg; P may also cause drowsiness or tiredness in some patients. If you experience any of these symptoms, do not drive or use machinery until the symptoms are cleared.<br />g. Important information about some of the ingredients of ALPHAGAN&reg; P Alphagan&reg; P does not consist of any excipients requiring special precautions because of dosing or administration way.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use ALPHAGAN&reg; P exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The recommended dose is one drop of ALPHAGAN&reg; P in the affected eye(s) three times daily, approximately 8 hours apart. ALPHAGAN&reg; P ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.</p><p><br /><strong>Instructions for use</strong><br />Alphagan&reg; P comes as eye drops. Always wash your hands before applying eye drops. Your prescription label tells you how many drops to use at each dose. If you use Alphagan&reg; P with another eye drop, wait 5-15 minutes before applying the second eye drop.<br />Apply your eye drops in the following way:<br />1. Tilt your head back and look at the ceiling.<br />2. Gently pull the lower eyelid down until there is a small pocket.<br />3. Squeeze the upturned dropper bottle to release a drop into your eye.<br />4. Whilst keeping the affected eye closed, press your finger against the corner of the closed<br />eye (the side where the eye meets the nose) and hold for 1 minute.<br />Avoid touching the dropper tip against your eye or anything else. Replace and tighten the cap straight after use.</p><p><img alt="" width="579" height="221" src="data:image/png;base64,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" /></p><p>a. If you take use more ALPHAGAN&reg; P than you should<br />Someone who has taken an overdose of ALPHAGAN&reg; P may have the following symptom, hypotension (low blood pressure).<br />Serious side effects were reported in children who accidentally swallowed Alphagan&reg; P. Signs included sleepiness, floppiness, low body temperate, paleness and breathing difficulties. if your child gets any of these side effects, contact your doctor immediately.<br />b. If you forget to use ALPHAGAN&reg; P:<br />If you forget to take a dose, apply it as soon as you remember. If, however, it is almost time for your next dose, do not apply an extra dose, just take your next dose at the usual time.<br />c. If you stop using ALPHAGAN&reg; P<br />To be effective Alphagan&reg; P must be used every day. Do not stop using Alphagan&reg; P until your doctor tells you to.</p><p>If you have any further questions on the use of this product, ask your doctor, health care provider or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ALPHAGAN&reg; P can cause side effects, although not everybody gets them.<br />If you&rsquo;re worried, talk to a doctor or pharmacist. Do not stop using ALPHAGAN&reg; P without speaking to your doctor.<br />Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.</p><p><br />The following eye side effects may be seen with ALPHAGAN&reg; P</p><p><br />Very common side effects include: allergic reaction in the eye, red enlarged blood vessels in the eye, and itchiness.</p><p><br />Common side effects include: burning sensation, eye allergy and redness of the inner surface of the eye and eyelid, high blood pressure, allergic reaction in the eye, dryness in the mouth, abnormal vision, abnormal taste, allergic reaction, tired eyes, inflamed red and itchy eyelids, blurred vision, bronchitis, cataract (cloudy lens in the eye), inflammation in the eye, bleeding in the eye inflammation of the eye, cough, dizziness, indigestion, shortness of breath, watery eyes eye discharge, eye dryness, eye irritation, eye pain, swelling of the eyelid, redness of the skin, fatigue, redness of the inner surface of the eye and eyelid, foreign body sensation<br />(a feeling that something is in your eye), digestive disorder, headache, high levels of cholesterol in the blood, low blood pressure, infection (primarily colds and respiratory infections), difficulty in sleeping, inflammation of the corner of the eye, lid disorder, sore throat, uncomfortable sensitivity to light, rash, itchy, runny or blocked nose, sinus infection, sinus inflammation, feeling drowsy, stinging, swelling of the see-through layer which covers the surface of the eye, tearing, flashes or floaters in the eye, spots before the eye and difficulty in seeing clearly.</p><p><br />Uncommon side effects included: a scratch or cut on the surface of the cornea, stye, dryness of the nose, and distorted sense of taste.</p><p>Some patients may have the following side effects (frequency not known): slow heartbeat, depression, hypersensitivity, inflammation of the iris, dry eye syndrome, reduction in pupil size, nausea, skin reactions (including redness, eyelid itching, rash, and dilation of blood vessels), fainting, and fast heart beat. Breathing difficulties, slow heart beat, coma, low blood pressure, low body temperature, decreased muscle tone, lethargy, paleness, respiratory depression, and sleepiness have been reported in infants receiving brimonidine tartrate ophthalmic solutions.</p><p>&nbsp;</p><p>If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Store ALPHAGAN&reg; P at or below 25&deg;C.<br />Do not use ALPHAGAN&reg; P after the expiry date which is stated on the bottle label and the carton after<br />EXP:. The expiry date refers to the last day of that month.<br />Do not use ALPHAGAN&reg; P If the solution changes colour or becomes cloudy.<br />Once opened, solutions may become contaminated, which can cause eye infections. Therefore, you must throw away the bottle 28 days after you first opened it, even if some solution is left. To help you remember, write down the date that you opened it in\the space on the carton.<br />Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is brimonidine tartrate 0.15% (1.5 mg/mL).<br />- The other ingredients are sodium carboxymethylcellulose; sodium borate; boric acid; sodium chloride; potassium chloride; calcium chloride; magnesium chloride; PURITE&reg; 0.005% (0.05 mg/mL) as a preservative; purified water; and hydrochloric acid and/or sodium hydroxide to adjust pH.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ALPHAGAN® P is a clear, greenish-yellow eye drop solution in a plastic bottle.
ALPHAGAN® P is supplied sterile, in teal opaque plastic LDPE bottles and tips, with purple high impact polystyrene (HIPS) caps as follows:
5 mL in 10 mL bottle
10 mL in 10 mL bottle
15 mL in 15 mL bottle
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>AbbVie Inc.,</p><p>1 North Waukegan Road,</p><p>Norh Chicago, IL 60064 USA&nbsp;</p><p><strong>Manufacturer</strong>:<br />Allergan Sales LLC,<br />Waco, USA<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in June 2016.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;يستعمل الفاجان بي لخفض الضغط المرتفع داخل العين في المرضى الذين يعانون من جلوكوما الزاوية&nbsp;&nbsp;المفتوحة أو ارتفاع ضغط العين</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;لا تستعمل ألفاجان بي</strong></p><p>إذا كانت لديك أرجية(حساسية مفرطة) تجاه بريمونيدين تارترات أو أي من المكونات الأخرى الموجودة في الفاجان بي-</p><p>انظر البند 6- معلومات أخرى في نهاية هذه النشرة للحصول على قائمة كاملة &nbsp;</p><p>أو بعض مضادات الاكتئاب. يجب إبلاغ الطبيب إذا كنت تأخذ أي العقاقير المضادة للاكتئاب (MAO) إذا كنت تأخذ مثبطات أكسيدي أحادي الأمين-</p><p>إذا كنت مرضعة-</p><p>في الأطفال تحت سنتين من العمر-</p><p>&nbsp;</p><p><strong>ب-&nbsp;&nbsp; يجب توخي الحذر الخاص مع ألفاجان&nbsp;بي</strong></p><p>قبل أن تستعمل هذا الدواء أخبر طبيبك</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني حالياً أو عانيت في وقت سابق من الاكتئاب، أو ضعف القدرات العقلية، أو ضعف وصول الدم إلى الدماغ، أو مشاكل في القلب، أو خلل في وصول الدم إلى الأطراف، أو اضطراب في ضغط الدم</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك حالياً أو في وقت سابق مشاكل في الكلى أو الكبد</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يوصى استخدام الفاجان بي للأطفال تتراوح أعمارهم بين 2 و12 سنة لأنه لم يتم استخدامها في هذه الفئة العمرية</p><p>لا تدع طرف القطارة يلامس عينك أو أي شيء آخر. قد يؤدي استخدام المحاليل الملوثة إلى حدوث أذى خطير في العين وقد ينتج عنه فقد الإبصار. أعد دائماً غطاء العبوة إلى مكانه بعد الاستعمال. لا تستعمل المحلول إذا تغيَّر لونه أو إذا أصبح غائماً. لا تستعمل المستحضر بعد تاريخ انتهاء الصلاحية المذكور على الزجاجة</p><p>إذا أُجريت لك عملية جراحية في العين أو إذا حدثت لك حالة مرضية متزامنة في العين (مثلاً إصابة أو عدوى)، يجب أن تستشير طبيبك فوراً بشأن الاستمرار في استعمال العبوة الحالية ذات الجرعات المتعددة</p><p>&nbsp;</p><p><strong>ج-&nbsp;&nbsp; استعمال ألفاجان<sup>&reg;</sup> بي مع الأدوية الأخرى أو الأعشاب أو الإضافات الغذائية</strong></p><p>برجاء أن تخبر طبيبك أو مقدم الرعاية الصحية أو الصيدلي إذا كنت تستعمل حالياً، أو إذا كنت قد استعملت منذ فترة قصيرة أي أدوية أخرى، بما في ذلك الأدوية التي تُصرف بدون تذكرة طبية</p><p>&nbsp;</p><p><strong><em>التداخلات الدوائية</em></strong></p><p>أخبر طبيبك إذا كنت تستعمل أي من الأدوية التالية</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مُسكِّنات الألم، أو المهدئات، أو الأوبيات، أو الباربيتيورات، أو إذا كنت تشرب الكحول بصفة منتظمة</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; أدوية التخدير</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;أدوية لعلاج مرض في القلب أو لخفض ضغط الدم</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;أدوية قد تؤثر على الأيض مثل كلوربرومازين، وميثيل فينيدات، وريزربين</p><p>&nbsp; &nbsp; &nbsp; &nbsp; أدوية تعمل على نفس المستقبلات التي يعمل عليها ألفاجان<sup>&reg;</sup> بي، مثل أيزوبرينالين وبرازوسين</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;مثبطات مونوأمين أوكسيديز (MAO) والأدوية الأخرى المضادة للاكتئاب</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;أدوية علاج أي حالة أخرى حتى إذا لم تكن متعلقة بالعين</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; أو إذا تم تغيير جرعة أي دواء من أدويتك الحالية</p><p>هذه الأحوال يمكن أن تؤثر على علاجك بألفاجان&nbsp;بي</p><p>&nbsp;</p><p><strong>د-&nbsp;&nbsp; استعمال ألفاجان&nbsp;بي مع الطعام والشراب</strong></p><p>من غير المتوقَّع أن يتداخل الطعام والشراب مع مفعول ألفاجان&nbsp;بي</p><p>&nbsp;</p><p><strong>هـ-&nbsp;&nbsp; الحمل والإرضاع</strong></p><p>فئة الحمل بي وقد أجريت دراسات المسخية في الحيوانات.</p><p>وكان البريمودين لا يظهر أي اثار ماسخة عندما يعطى عن طريق الفم خلال أيام الحمل من 6 إلى 15 في الفئران وأيام من 6 إلى 18 في الأرانب. حققت أعلى جرعة من البريمودين في الفئران (2.5 ملغ / كغ / يوم) والأرانب (5 ملغ / كغ / يوم) تقدر المنطقة تحت المنحنى 360- و20 أضعاف أعلى، أو 260- و15 أضعاف أعلى، على التوالي، من قيم متشابهة المقدر في البشر تعالجوا مع الفاجان بي 0.15٪ أو 1% قطرة في كلتا العينين ثلاث مرات يوميا</p><p>لا توجد دراسات كافية ومسيطر عليها بشكل جيد في النساء الحوامل. ومع ذلك، في الدراسات الحيوانية، عبرالبريمودين المشيمة ودخلت حيز الدورة الدموية للجنين على نطاق محدود. لأن الدراسات استنساخ الحيوان ليست دائما تنبؤية للاستجابة الإنسان، الفاجان بي لا يستعمل أثناء الحمل إلا إذا كانت الفائدة المرجوة للأم تبرر الخطر المحتمل على الجنين</p><p>&nbsp;</p><p>الأمهات المرضعات</p><p>ومن غير المعروف ما إذا كان يفرز البريمودين في حليب الام، على الرغم من الدراسات على الحيوانات، تبين أن البريمودين يفرز في حليب الام. بسبب احتمالات ردود الفعل السلبية الخطيرة من الفاجان&nbsp; بي في الأطفال الرضع، يجب اتخاذ قرار إما بوقف الإرضاع أو وقف الدواء، مع الأخذ بعين الاعتبار أهمية الدواء للأم</p><p>استشيري طبيبك أو الصيدلي قبل استعمال أي دواء. أخبري طبيبك إذا كنتِ حاملاً أو إذا كانت لديك نية الحمل</p><p>&nbsp;</p><p><strong>و-&nbsp;&nbsp; قيادة السيارة وتشغيل الآلات</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يسبب ألفاجان&nbsp;بي&nbsp;غشاوة أو عيوباً في الإبصار. هذا التأثير قد يبدو أسوأ أثناء الليل أو في الضوء الخافت</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي أيضاً ألفاجان بي إلى حدوث نعاس أو تعب في بعض المرضى. إذا حدثت لديك أي من هذه الأعراض، امتنع عن قيادة السيارة أو تشغيل الآلات إلى أن تزول الأعراض</p><p>&nbsp;</p><p><strong>ز-&nbsp;&nbsp; معلومات هامة عن بعض مكونات ألفاجان&nbsp;بي</strong></p><p>لا يحتوي ألفاجان بي على أي سواغات تستدعي اتخاذ احتياطات خاصة من حيث الجرعة أو طريقة الاستعمال</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>التزم دائماً بتعليمات طبيبك عند استعمال ألفاجان بي. استشر طبيبك أو الصيدلي إذا كنت غير متأكد من طريقة الاستعمال. الجرعة الموصَى بها هي نقطة واحدة من ألفاجان&nbsp;بي<strong> </strong>في العين المصابة (أو العينين المُصابتين) ثلاث مرات يومياً، بفارق 8 ساعات تقريباً. يمكن استعمال ألفاجان بي محلول للعين بالتزامن مع المستحضرات الدوائية الأخرى التي تُستخدم موضعياً في العين لخفض الضغط داخل العين. إذا لزم استخدام أكثر من مستحضر عيني موضعي واحد، يجب السماح بمرور 5 دقائق على الأقل بين تقطير المستحضرات المختلفة</p><p>&nbsp;</p><p><strong>تعليمات خاصة بالاستعمال</strong></p><p>يتوافر ألفاجان&nbsp;بي في شكل قطرة للعين. اغسل يديك دائماً قبل استعمال قطرة العين. ستجد في تذكرتك الطبية ما هو عدد النقط التي يجب استعمالها في كل جرعة. إذا كنت تستعمل ألفاجان&nbsp;&nbsp;بي مع قطرة أخرى للعين، انتظر 5 - 15 دقيقة قبل وضع القطرة الثانية</p><p>&nbsp;</p><p>استعمل قطرة العين بالطريقة التالية</p><p>&nbsp; أمل رأسك إلى الخلف وانظر إلى السقف</p><p>&nbsp; &nbsp;اسحب الجفن السفلي برفق إلى أسفل بحيث يتكون جيب صغير</p><p>&nbsp; &nbsp;اقلب الزجاجة ذات القطارة واضغط عليها بحيث تنزلق نقطة داخل عينك</p><p>&nbsp; &nbsp;مع الإبقاء على عينك المصابة مغمضة، اضغط بإصبعك على زاوية العين المغمضة (في الجانب حيث موضع التقاء العين مع الأنف) واستمر لمدة دقيقة واحدة</p><p>لا تدع طرف القطارة يلامس عينك أو أي شيء آخر</p><p>أعد غطاء الزجاجة إلى مكانه وأغلقه بإحكام فوراً بعد الاستعمال</p><p>&nbsp;</p><p><img alt="" width="570" height="218" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA6wAAAFoCAIAAADcv+GYAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAADsMAAA7DAcdvqGQAAKzuSURBVHhe7J0HYFTF1sezvW822fTeO6ETeu8dVLCAYC8gIAgI0osIiqDSQexK7733HhJ6Gum9Z/vebd9/7kYf+r1neeIjyvyM4Wb31jkz5/zP3LlzOQ6Hw4VCoVAoFAqFQnmc4Nb/S6FQKBQKhUKhPDZQEUyhUCgUCoVCeeygIphCoVAoFAqF8thBRTCFQqFQKBQK5bGDimAKhUKhUCgUymMHFcEUCoVCoVAolMcOKoIpFAqFQqFQKI8dVARTKBQKhUKhUB47qAimUCgUCoVCoTx2UBFMoVAoFAqFQnnsoCKYQqFQKBQKhfLYQUUwhUKhUCgUCuWxg4pgCoVCoVAoFMpjBxXBFAqFQqFQKJTHDiqCKRQKhUKhUCiPHVQEUygUCoVCoVAeO6gIplAoFAqFQqE8dlARTKFQKBQKhUJ57KAimEKhUCgUCoXy2EFFMIVCoVAoFArlsYOKYAqFQqFQKBTKYwcVwRQKhUKhUCiUxw4qgikUCoVCoVAojx1UBFMoFAqFQqFQHjuoCKZQKBQKhUKhPHZQEUyhUCgUCoVCeeygIphCoVAoFAqF8thBRTCFQqFQKBQK5bGDimAKhUKhUCgUymMHFcEUCoVCoVAolMcOKoIpFAqFQqFQKI8dVARTKBQKhUKhUB47qAimUCgUCoVCoTx2UBFMoVAoFAqFQnnsoCKYQqFQKBQKhfLYQUUwhUKhUCgUCuWxg4pgCoVCoVAoFMpjBxXBFAqFQqFQKJTHDiqCKRQKhUKhUCiPHVQEUygUCoVCoVAeO6gIplAoFAqFQqE8dlARTKFQKBQKhUJ57KAimEKhUCgUCoXy2EFFMIVCoVAoFArlsYOKYAqFQqFQKBTKYwcVwRQKhUKhUCiUxw4qgikUCoVCoVAojx1UBFMoFAqFQqFQHjuoCKZQKBQKhUKhPHZQEUyhUCgUCoVCeeygIphCoVAoFAqF8tjBsdtt9YsUCoVCoVD+53A4tEOKQnkE0IZHoVAoFAqFQnnsoCKYQqFQKBQKhfLY8RCGQ9jtdi6Xa7FYeDwewzBCodBkMuETfC4Wi52f4M/6tSkND5vNxvkRh8PhNCgWrFYrvhUIBPjcuSalYQILwl6wGiwF82EZH6I9Oq2JtokFqVTqXJnSEIBFnMYirY7DgZ/Ebz6fj6+wjEZHfeZjBR0OQaE8Eh5Cw4NUgkNHoIVDhxP//PPPR40adeLECSzjc5FIRL15AwdqCb8RemFBWBM5jNlsxgIiMYDAwufONSkNCqfGdVoHrQzAcEajEXIKy86GiWaIXBSJqHMTSgMBzQrATFhG04Ol0O5u3Lhx7ty52tpa2BSfONekUCgUyl/EQ+gJhiuHAsZv+O7jx48vWrSopKR05coVzz77LD7ECs7uDUqDxdmLX1dXd/PmzatXr2ZmZsKUsF3jxo27dOmC33K5HLqqfm1Kw+BHBYzfpJUZDIaioqL8/HzoYIVC4enp4e8foFKpYDisySpkmos2INC+nKZxdtiXlZVt3Lhx1apVHh4e69ata9asGb51ZqeUxwHaE0yhPBIeggjWaDRz5szZu3efVqthGAv+lEqln376yciRI+HcAUQwlVANGcTjtLS0pUs/3rFjR8eOHYYNGyaTybKzc3bv3n3nzp0+fXrPnDkzKioKazrDtnOB3ZTyyHB2FuI3MpYNGzasWbMGZoHqlUoler0BKY23t9eoUaPQDJHDWK1W2hncoDCZTLAIMhYo3ZKSEsjfrVu36nR6Pz/fFStWJCUlCQSC+lUpjwFUBFMoj4SH0PAUCsW4ceO2bdt69OjR7du3dejQ3hmbuVwu/DtVwA0fvV6/fv36/fv3zZ49a/PmzSNGjOjRo8eECeP37ds7ePCgTZs2b9z4hcFg+El1QVHVb0l5RMAQaF9oWQzDrF69etas2b179z548MDly5cuXLhw7txZtEe1Wo3sdNOmTdReDRBnTiKRSO7evTtx4qTTp8/MmDEjKirS+UAFcGabFAqFQvnreAgi2GKxeHl5xcfHx8TEREZG0sEPfzsqKytPnToVEhL61FNPCQQCRF/EZq1Wi/Rm8ODBfD7v6tUriM3OMabO9KZ+S8qjA4aAUUpLS1NTU1u2bDls2LCIiAi0PnwO8zVr1qxLly5IXa5du0a7gRsgaEo2m+3SpUtjxozRajUbNqzv2bOn1WpzcSGPx9EmRqFQKP8DHoKr5bBj1376Xf8p5e9DSEjI6dOnjx07qlarnUMVGYZRKpUZGRlz585FSB4+fLirq+tP6Q2N0I8W6CfnhA8Qu8HBwd9+++2RI4c7duwIw+FDWEev1x8+fHj37j3+/v6DBg2CAoZcrt+Y0mCAjd5+e6KPj8/nn38eGxuLT5DACIVkXgg0QOc6FAqFQvnreAhqBtoXvtspf53jH5yf/4SzBxELEFjOaQecn1MaCDCfQqGAosIyAjBsVFxc/M4778THJxQUFC5YsODZZ5+FWWFcfCugM6b9OYiENTNWxoIfaB2zmbHbSaegQa+3WW1Wq81sNGKl+rX/HSh/6Fpnzum0CGwHA1VWVjpHAPv5+SFvkUjE69ev79q1K9YRi8X1G1MeET+lLlhGTrJhw4Zp06a1adN69erVsJezTYnFInxlNBphXFQJ58pwmD9tSKFQKJSHyMOZJxiySSQSYbm8vPyFF144d+78J58sx4JzBbhvp0N3hm0nzq8oDYGfspSKioqtW7du2bLl6tVr0dHRzz8/ctiwYQEBAVBR1GQPCxQ1SRrRcBxYtuM/5BfQwVA/NotFqiATcfz/TPIXQD2zvYZkkIPTNM5Wlp2drWG5cOHC99//gIYJI44dO9bDw4PdjvLIQCuDAzQYDEhIjhw58sILL8J8rVq1RP4JM0mlUljt/PkLsGy7dm3lcsXgwYO6deumVCqdlkUbRK2gzfCfCn0wjkJ5JPwvRDDcujNaY038poqqAYIAvHTp0k8++dTd3e3tt98eMGCAl5eXgJ2xH185Z9qqX5Xyp0HAI1kHfkipOkjvr8mYfOlCQX5BaFhoo2bNFQol+9V/BKrIYrGgWUFU6XQ6SCWJRAKZhSYGq6E94quzZ8+OGzeuuLj4q6++6tOnD0xZvzHlf45TyELFwmr4nZWVde3aNQhf+EZ8DueJ3zU1NStWrEAu9Oqrr4aEhERGRkZERMCstOk9DlARTKE8Eh5Cw4N/R3wlQZ3t7XB+iGAM4NnxOVw8/HhqaurLL7/s6ek5btx45zoPFwQKjgvOwYHfv1jGArvK78G5LVn4cbl+P+y3/0yqq6snTZq0du26CRPGQzmNGTMmODjY+YQcj8eDAsY6WAbO9Z2WxW984vzt/PwP4Szn3/FTX/7/brl+HSc/LT/4+38BKRgyWy/514HCcbHZXaw2/DisWHZw8GN1uFjs+JN8YmIs5eUVBXn5Z8+e+XTpR2+9/HLHtm369Or9ww+bZDJZZGy8QCD69QLFYVD+MBAU1alTp/r06Tts2PA7d+44u4et7FtO0CR9fHxgPpwSfv/UQp08uEz53+BMQmC42tpaqNtnnnlm4MCBgwcPfuqpp4YMGfLEE08gUXF1JdlmUlISPo+Li4MCholh2R07dhw8eBAJj3NXFAqFQnkoPISeYKPRCGft7HwqLS3duXNnSUlJr169WrVqhVjL5/PxFX5Dae3evTslJbVnzx5Dhw6t3/gh4ZREv4LDheMg2uk/wuEQdVX/x38AO6lf+geBqHz06NHnnntOLle8+uorBoMRkglCqv5rlsDAwOHDh0ulUqw8e/acY8eODRs2bPLkd6Cu8C3CNnCu+fuBPX6jvH87Qfvtg/7VWg9nwGYENhyIxxOghhhNZIwvZCi+MzMWC2Pl87lmsyk7K/P2zRtXr17Oyc6x2axBwcFx8QnxCY2aNm9hMxulErG7hwePR+Z2sDBmIXtf5T+BZvWT2C0sLJw5cyZa1ttvv/3GG2+4u7vDKGiSt2/f/uSTT44cOfrUU0/OmTMHyWdNTQ0+gVDu0qVL165d0STrd0dpAMCmubm5Y8e+VVZW+sEHH8BGEM2wslar/f77799/f5FSqTx8+BBaYv0GlH8WtCeYQnkkPAQRbLFYnJ1SiL4QQz8twK07/TirkQgI24jBWBnUb/y/ghXB9cvAeR+a1Ugc8r+LA3//pgj+RwKLbNy48ciRI057IVfx8vLS6/X1X7MgJL/55ptIchCSIaQyMzP79esHHfyTrf8LRUXK/9f7I1GF6pcaLrgKm5XR63RIHgRCiUyh4PL4NrtLXa0WQe36tasb1q25cu2Kl9qtb/8BA4c+4evjp1C6anR1cplCJpVhD1arRcjn8XmkpxZi+se28xvvqWZXQOMlFBUVLV++/KuvvjKZzP7+/nK5DLmoRqNt3rwZlHH37t1lMplOp4NNw8MjsO3cuXMmT56Mozh3RWkIwI5oTQaDAW0Q2abTc+I36gM+N7GTB+NzarV/KlQEUyiPhIcgggHULZw1vPaDwhcLpIeM7bXCMnQSVsOfUMAP3ZU7e3mJZsKeSYct5BVRtc4voHBJt+Ov9jxy2dWdm5C//7Uf5zLZz99Blf03wCjOBdgLloJ1fmEgp0F/Wg0L+BOiytk37NRt2ND57e/kZwf4d9j/jU3/ZQuStTi/dP7zwMJP4BOy5V+K3a7V1FZX1+Tk5Fw8dz4lJcVkZrr37P3M86NXfLJ83749kyZN6dWvr0Qqgp5xFqvD7rDZ7TXVlUKRWKFQkLNkx4ny2XZhtVptVotAKGTX/Y84WxbKHPIIDQpbQz/BTBqNBr+herEOfsM0DwhrB3IYsViMlZ2f/PohKP9jnO0L9kJe6hwlDAPBUvjQaSlqr38wVARTKI+EhyOCf4HTm/+lLhtHgAKwMAyXDRLlZRVKlRs0uEAosFlJFJFIJZC1NptVr9OnXEvmCwU3b960WpiiwqKqmpqw8PB7t2+JJJLQsHCJWJyXm6Opre3du7dILFKp3KJiYnwDAirLK2oqqyJjo3Ozc0JCw+pqa4QCrlRKBn5Ao7Aygih7XCy5Ic4+kyRkRz87z5DyIIjo+A2hh99WqwVSj8vhQsex8pYLgQbT2OwOsVRKag+7NulPral1Vbn98M2XgcEhrdu0RxaDEjYZjNCTThknEAmh2VHyZLe2+nd5wCiQ5NgJ9LyAdLLyyMRj7OdYmcjo343zXAQC8lgnFiwWi8MOjWqFwa9du3r0yJHkq1flCllwUHCrVq2atmyl9vQuLy2bPXtWcVGhwWgcN2HS8GdHoNrgZNlGQWoHDo+K+lM9wecoBPzxs09+90myu/1lW/tpD39oVxQKW1t+UZd+46bEb2IyosHy0Iiwc3hmi9nE4fIkEgkqroX1pVwe1X8oeVoIFMoj4C8Rwf8DyC1CoxGeQ6/RwsMq3NR2O8dkMhUX5G/fsrmgsKCysiI9Ix1ia/yESbnZ93kCiVQq5vH5w58bOW/Gu02at+Bz+bPmvPfqS6/16N175+bNfJFo5OgXJk8ad+VqcmRYaHhIaH5xsUAgGDJosJ+vX49+/dw93LkOMpW9Qa/n84kChioSicXQGYgT+B9n5exGdZ4h5eegWByMyYxshMcjmYNeryeqVyKBpUw63YWzZ58ZPdpuJ5877FaJRG4wMWKxuKiwoHePbr7ePj9s2+HhSeb5gmqGarxw5oynp2dwRJhWU6dSuSPEwhyQ0wCpEV8gwHpGg1YAHUwQwkJEHP9x48DQZqORTH/NjuHR1NS+PWFc8rVr782cGRsX5+vnIxIKcVy+QMTl8kklcOGePXv+6eFPGo2GPn36rV7/hatczCeZGoXS8Pn/LYSt1H8KZIDEQ+IX/iB5qt3GFwrtaP/EZyJjhTt1rvn4QkUwhfJI4M2ePbt+8W8FFLDVYoUySUm+emj//hPHjl+5fHnb5h+EEknnbt2qq6rd3d0//nRVZET0wQP7evXuW1hUuHff3ls3b4oE4hs3U8tKK2QK1zOnT1RVVd28caO4tCQ7+352ZmZebq6ZYd5886335s3Py85+7bU3lSq3KVMmXbtyuaK0bO7sGedOHLfarO5qD8ZI5vt0Rgh25B4fv53nRvl3cGAv6EKiVu327MyM9HtpKrU69dq1Pbu2yxTKKVOnIA42btr8+JEjWFkmk1eUV45/87V27TsxJlPK9estWiVt3bTps6VL8W11Vc2XGzcsW/aR3cIEB4Xcz8rcu3N7ZWU56oPFwvC4vNz796sqK3x9/chIDrudzVXsMNYfHbMBiF7XaYkI5vML83LHTxhfXFi47JNP2nfs6ObmLoD4FQlheqvFYrPaSDjn8lyVSheb/eLFi1DwgX5+TZo04XGJuPhPPxRKA4HoU3biFyeQrf9Fk/kFFou1qqLy+uXLe7Zv/+bLL3bu2IF2gWrv5q5GekqGPbG5a/3ajyu0BCiUR0JD6Qn+cewmfpMbx1arlYxt4JOZnogndnAcLhxyW43Lx5opyddOHD96PzOzX/8BNXV1p0+cUMjkQ4YNb9oyKT83127nyOTSzzes239gX9duPa4lJ2dlpkul8rq6OqiT6ppq7DCpZZvY2Lir1y4H+gc4OC4z58y/npy8fOmSRolNTp88BgXm5+9fVFy8ZPHHR44ccFWqXnz19XGvvzDtvZkrP12Og1aUFN++c6tzl24Smbh1m7ah4RFO7YX/LAyDnJ7H57GX8k91bbAR6Y+t/4Nc6oM/RDgyjA3FQMY6kDHi5FNE19raOsZCxjvu27V7yYdL3NTuL7/y+pmTpw4fOcBYLNhuyNAnK6uqbt9I7d6zd3FR0amTJ+QKpcFosJhNQrEYtYIxM3wBeWUAqSQWi4enV9u2HTIz07KyMhVyGcK3SqVSu7kVFBWpPTx69uhh0hvUanVUVFRAYFBSm7YisQBbkaEUSF3ILw42cRqJPU87BLeInZmV7a9ywKBmk5Es2m1CoTj58sUpU6e2bN5i1vz5SldXo8HA43HFYqHdZkXNhALGJ3q9kScQVlVXT5ww4fjJE926dP10xUo/P19Eehc7e1CHgx2VQYZA1BfXP0IJwyJmixVJAFJCFB3KGYkH0g9cG4oPWQQZMkQUFsqK65w2kS1X8hFpOjysYLGxw5zIPoj2IsWCNRiGgcnYzn72oQLar/4jv15vbMR1kgnyGMaCkhaLhKjqziInhUyW4WnNqH8Coai4sCA3+351dbVOr4ftXF1dY2LjQsPDRWLRL47yY9snzQbmsNvsHOR4bEcmcdX/L9UkLQ7ZKWNB4ygrKamsqCgsyC8uKc1KT5NIZU2bNevWq7entzdpdKhCJhN+S9iHDZxNEnvg8wWk8TwA/IDJaMDmfIEA6+BMfnHQR4JBp4P3QAgQikRmo5EM7vp/kFL7d9CeYArlkdAgRPCPCrgeODWLxYKAJxQK+Yh80D42R3ZWzoYN606ePFVVWTFv3gIPtefnn68xGIwzZ8/18w/87qvPGbPZx8envLLS28dv0+YfCgqLyiurBg9+Iigo9MCB3dHRcYzRmJF+h8O+tAkS28PDAwHAzd1Dr9VGREUhrsLVJjZpvvSjRRWVlVKZzGZl1GoPlaubl1+gnTEXFuZVVla1adly6YrVaz5d9vwLL/p4e6XfvpWWcW//3r19+/YdNHSot58/64sdpDOFnTZLKPxfz4PxP4FEP2ckdP4Bo5EfDultZb/iIrCWl1chmAlFUkS1mzdSv/7ii6bNWnL5glkzp+n0upjYRqmpyUqlMj6hMVSsRqcz6vXYlARZBGcXF6RAZPAJhCaXi3COOAoJ7DwiOQo5OgdaimhYBF+rNSw8sqS0GNmISuWm0+kiI6N79Oi7e8cm2CMwIOjq9StymTzAPyAw0D8uKrpz587NkpKQq6Bqaes07mp3qFLEaT6kmMOFTWmQyQhwLnwhEcvQYXw+/1ZK8tixbzVr3HjRx0tFIgk7KgYHt5lNBgGPLxRJHDaY3gqpa2Tse/fse/vtsSiK+fPfHzn6eRLU2TOH+oCMQ8THlmzRkfIipfj3hzzL+ECMR3miLaOQsYC2jEYNHYbvzWZT3v37p0+eSE9PRwXo0L5Dq3btFa6uOq2W5I8CMoYamxN1jM3JVMekWqD8yQIsQgxCIfx6QcAcOr3BaDSRl91wOTqNDoUvV8iRY5SXlN2+kZKVmX756pWKslJkifGNGiOZVyrkCoXSLzBQJpej/JEBSiRiNiGphwyvd86fyBoahoHVBOTF3VI0V9gLrReWIiv8Z5yPbSBBMplM50+d+PKLL6EaXxszpnmrJORC+MoEBSmRwPTOWMDjciTif00ayGpl862UFL5Q2LhZM7iLutoa9wbwTkQI2drqapFEjAU+j7dnx7a+gwaT3u4fgbugIphCaVA0lJ7gB3E6PofNzjBmvV5/+sTx737YHBQYPPqVV2dMf1cmkXAcDg8v78FPPSUSiPbt2lFYXNSn3wCTybpl07cZWZkqlXtQaKjZYKypramqqQoJCy8qLCoqLLBbLQiu8EBSiRiRAZ6ULxSEh4S9/Nqbbdu312v1Bbn3l360uLqmJjg4VCqXZ6anIX5IZXLIrMrKMuiq6IioxIRGVrtt7oKFMon42y82dujUef/u7U89/Yy3t9fFs2fLykpbJLWOio2RyxXOuSgkEonzov5ZsJ02P/PmEHJEzzl/oP/1OqNYKs/KvP/hooUxMXEjXnpl5nvT9u7d3SguITP7fll5Gen5s9tJx5SD3BBFwLNaLKTfmO0IBAilSqmssrqKBD0S7nFArtVqQRTBV/gNZeyucqupqcIeUOAkZpvN2Am2xSbNW7ROSmpz4vjhl195o2XrNvNnTx8/fiKX4zJl4ltKpaufn9+Zc2dbNW8WExPbs0+/6Nhodw8v52hFRF8cC4oBhxVLxKiEtTU1yIsy0u4eOXwoNye3V8+eL7/xpkAghFDQ1NZK5TLSx4bgb7XiUnhcHiS82WrXmYyL5s9fs2ZVqxYtl3z8SXyjBGhfcikOh5B0Zv/TRDDKTqMxQJcgdYUJLRYraw6muKjo2uXLNdVVJrOZ5+IQCPnIOSOjY9Vqd7PRpNNrYX6LFUkv6c8zm1EHOEKhCP8hr0CaoXRTScQSZ4WwMIyAz39QD1F+BbOJYSxWaDIkIVCut27cOHPyRG1tLWRZXKNGQUHBJqMBX5SWFBt02uqqahmZq4TMaY0UTSaVIi0BAcEhKPP6PRIc2FVVeXlZcXFtXa3FakPSglotFAhCQkOatWzl4eX1n3SeE7vNbjIZ0dawGhIkcmvAZq+tqzt/+vTpkydlclnrtm3jExKDQoIZC0lKpTIZmgl0cP32bHZUXVEJDX36xDHUi5Zt2rirPX5Tef9v0Gu1QpE47e7tC2fO9B00yC8g8MHSwPKDfz4IFcEUyiOhQYhgIqCIYiQyCv4OXhKOOPV68rdff8N1sXfv2fvmnXuHDh4YPPTJFi1abPx8w53bNwcPfgLaND/3PsTx1u1bSsvLTSbytg74TalU7uGhLi0rNRiM8DiIzeRdHhbGYbW6uaqS2rRPSU2GWmVVF+Pp4fnCiy+/OuYtlVIh4Doqyso+WbZUKJaPfvG1xR8s3LJtk8PuEhQcqtPrcBruSsV3334pkUibNmkqEvCHPvnUiSOH3N3dJk2bxufyRCIh1N/dOzdvp6S6urnFxsdDi8ODO6/xnwURwc4lKFOi6378gIg8YlAEYDPShsrKqpnT3029eSMhvlFBQV5FZZWZsWi0WkQ0CECrmRGwt8sR1bBLZ0+SHVER8tZhx+fOvfGFIgRelcrttdfHIiofPXL43LlT5MhcntFk5EJ02mzQS/jNBhhIaGzHIft0OGCs4KBgqUQiFIufG/H8pu+/uXv39odLlsYnxE+bPHHp8s/uZ2acOHG8UULCsGef1dZpridfS7t3D7uIiYmpqqq6eOFCUWG+WCxp1DgxKal1SFiYn3+AAPKMvX+v12nXrFgRExffpn0HT08PDuoKe2cfJ80wVpPVnpOdM3nShHPnz40cMer9Dxbj4qRSCVF3COn/OBGMy7BYHTw+V6fV3UpJOX/mdHFZSURkNFJHDo9bXVWZk5NdW1WJ9VQeHt6+vq5yuUQkCo+OhuTlsa+4g8nYzIr4AJJDIpcwm+5nZFTX1mg1OiizJs2bJTZpSlIOCmllbN6Jf36sO/9aJu2GrKDTaXMysw7u35eZkdF3wEB3d/f8/Lz8vFyL2aL28kS7QPrn40vmrubzeEKUrFAEicy2I3I7C74YCvin/QOyyP5NbteQezakveLAVnb6S5FIhCwIaSy77r+H3YoMmXAOmOHxBfiTw3b61lZXZ2aknzh+7OK5sz179R723AjkqzikVCLlkmv9FzYy3QsR0xl3797Pykpq0yY4PLz+u0cHY2YqystQ+S0WS/NWSe4eHsjl6r9jIRL4wdJ8ACqCKZRHQoMQwYzFXlurhXOQyeUQB/czs6ZNmaRUKF997Q24b8ZmbdO+073bd+FtN23+xs/bF34zK/u+UMAXSaRVVRVvvzP17q3bN1KT07My1e5qRNIaTZ3FYuZweKFhkX7+wfez0rSaGsgyiYRMklpbU2t32JzD14gc4XJ7dO81b97CyPBgs8FQq9O+MOr59IxMrV5vZQUZcV2kJ4qM+sTpJcY3QYqfl30/+fJFby+v9xd/GNcooa62RiJGDOGZjAaZXHE/Pf38qZMyhbxj127uHp7w9RBYiD3QcCo3d6XKFUfHf7h2yb8bN9bAYWMgx2q1QKrwBXwXF66Z3CO1cvkCk9GCRa1Wk5+dVVVZsW7tmrPnzqIQ+QIyBjQmOiYkPOp68tWSkmKbzYpPnFEce7Sz3cAkFJBHxTl2m5XEBefxWGC4Ll16JiW1zM7OPnLkYEVlBdns16KtC0zbtGmLkuLCkpIiNsY4ZBJJ5y7dly77JOV68vw57+3cc0CpkG394ftjx48adIaSslK1m6pzl67ePr65uTmBAUHde/YIDguF6ev3SCCnazToIdlrqqq//WLjtdSbCz5Y7OfnJ+TzdLU1CrkCtUsgEhmMJhNjXb961YdLP1K5uq5eu6FZ8+ZIvcQisVDYQIdD/CRQnJcMoxoMBjKrMNvN5hyNza5IgIgxm0x8vkAoEjFmM66kpqb26KFD58+eCY+IaNys2fnz5/W1tXyRqGmLlsgbvcmLQmRocGbGjP3DIjgYMor63bFADrEjicgsyM7+fmgdnBd7XHJo0iPoIJ2RTv2EcyNi+VdwOIy4BKEQZ1tVWYlczd3Tk+3sJ8O+nZcgVypI3fu7QW44WGwWMmAaLY+ILTN59aCMYRgUL9TYxXPnPvzwQwtjHvPGmHtZWVWlxY2bNmvStFmzFi3kSiWRrShcuw1pG2xB3hNpseKfB7tUUeLEUPV/EXA4NGeBAEqXi0aKY8FSaIdkM+IKUMB27I0VuA6+QIBm7rRj/fb/j5+k/E9gWySia1etSElJfWrYsBHPj1Io5BazWSqXoWYgtRbiSAKBWCo1Gg24hFOHD6ekpr42ZgyXx5fK5QadTq5Q/EJ9/hWQwdBoxg57bU2Nm9qDYczIlr/5fH1VefnLY99CUZCUgJTJ74J1UBQK5X9NAxHBDo1WB3+ckXZv9coVrdu0fXL403t37Lhy9coLL72cm3N/5ao1pSXFiHbVNdUCPh8hEkqLsTC+Pn6VlRXBwcE8Lrdjx07devSGlz9ycP/0ae9yeFyDUc/nCby9vLv16Gc2m/bs3qY3GODxLWYj6X6A93I+e0FmOhN1aN/x46XL4PG//vKLNevWmExm7B8+Dkqa+Gd4dBcHnCzWF/J4MTFxSUmtr165cufOjUaNEuPi4gL8/J4aPjw8IowMWHS4IE7Ald9ITsZpN2rS1MfPXygQ5OfmFOTnV1dXx8bFB4eGQkXBU2OHzkL4G4GAxphMJEGwQbRAzfHMjLWmTqfR6VBS27dtXbNyOUKRWCx+5pmRbm7uFy6cvZ+TU15RLhWLEVRVKvfQ0MjMrLTS0mJiAqJjSMcSsQU7OAJhkQMFC+oPWA9s51yBfE4mF2ZP5VfADmA29qUSMLaXp3d4eFhBQaFAIKipqsTpL5z3fl1d1SefLhv9/AtdunVzc3eD8JVCxUK1s1LAbDSq1G4PnojBoIPZjAYjTlmhUJaWls+cOcPXP3Dc+PEe7ioyrJh9SbhAJDRAKIsld+/cGfPGm8mpqX179fpm01YiMq1WmUzaAEUwKVtSzZ3FSgQSsgi0I1w++w0ZnvtgUaCGW602Ih8dSFwzv/3qy207d2t12lYtW0ZGRnXu2jUuLt5VpYLeQqlgHehdxmQUCHhQzdgLMkwHmp5EXL87FityTlYV4ehs9bKjLPE5OTx5vpLkjTgemyyR3njyz6/2OwKb1WYEevLOvLTbt1NSric0btK2Qwe0P+zp79sMraTrnU2mSeGQ6atRySFGs+9nHdq/f+euHelp6R5qj4SEhKFDn2jdtrV/QJDdhrZAbrmgAEmB2m0WC4OUAB9a2RceQQM/aGIsOUWws/zxPzZEpcXKpFmxG5CnwcRk0JdBr8MnaPUwDhtWsCoaKbH7g/v8Bf9fBANkJvgpKSk5fHD/iWPHYOrhw4cNGDQYZyEUicmTZ2IRhLCmrlYmV+C4J48cQcXrP3ioVCZDCeCqflGv/iJwpUjYkAFKpFK095OHD2ekpb08ZgzUMGomTgxy/Feu/UGoCKZQHgmPXgTDCTJWe35ewVefb7DZrK1at9+2dZOvn1+v3n3hSg7u33vs6JFuvfpJpOIN61ZXVVdJpXKVUhUQEHDt+lWLxdIyqe3kKdObNklQKaQQFfB9Vy9dGj16VHllBTx1UGCQRCqrrKo26PWIF9DKAYFB0F5VleUkDLi4QA3jFHBchFNvDw/EwqrqasR24r6Jx+fC7cIFi0QQsYI6jRY+nfVWDsRmK2P28fbq2rkbNr9y9VK3rt369+0dnxAfEBRsNJL+M75ACD949fLlmsqKzt17uLq7I1DV1VQXFxdfuXAhJCy0R99+D/a7/F0gQdHuMBkMQgQ8Hr+mVqPR6n/47vs1a1fW6XSIXhKxBDEZwTIiPNLVVZWTm1NaAXNYEEU5LojBYpW7u7auFikFMg2T0chhH4QCdqtNLJWIRCLoFSz/In7AFjAKh4gfkroQ8fir0+yT/kMy/xLZEKaMi01o16HTjs3fIpWCHV1dXce8+daOrT/Ex8Zs/Pb72ppamULOdeHkZGd7+/i4q92hmkQSEZFKPwd7RRhGGiYSiU2M9fLla8s/WvLSK6/269fHajYJWNXIF/CsVrMVrcvu8s3X30+dOkUikSxasGj4iBGkG5jso8GJYJwDCsrGTsGBpJGVF3q9Vqv28oTKgeT9RU8wVsq5n334wP6du3fn5uWp3dWdu3br3qNn4yZNZDI57AjZhPV5JO0kLwQWo1qIRXXVVQajwdvHl3QTWsm8AfW7Y4EIhvJFu0bJkR5EF1LUzu5J/IYgQ62zss9UCUUi/I3i+02NgQpJFDOfDF3F5UAC3rlx4/KVy0in27ZrFx4ZBafxtxPBuHCrzUVvNCJrEYskOo0m5drVH777+tadO/kFBeHh4T169GzVKimxcRMPT0/yYKJIhJKEFyVpDtJIVvUa9XqBCBpVWFtdXVlZoXJz9/T2ftAjoWhJjsGOdrBiLwxTUFCQmZGJ7AP5j/Nt4a6uCg8PLxiH5L1SCaqB2sMD7hG6UCaXoyJh4VeK99+KYKLPyTORXByzorw8+erlNStX+Pn6TXxnckhEOBl7Bs/DqkySwYhEEKDfffGFXq8b/cqrqL1qT+LJ6/f1l4HqhBLCeaLJ4DL37diekpw8Yeo0tH2l0hVinT2Hn1/Yf4aKYArlkfBoRDDrPupBJn3t8tXiomIen3f29GmVu1tS23YikWT3zu3J164GhUZER0ffvXnrXmbm3bQ7nh5eEB9VlZU4bfjumTNnjRgx0sNLbdIb5a5Km80OlYzAOWXSpHPnzlps1rq6ukYJTXx8fLQ6XW5+XmlJiYkxk94OyC3yjDP8L4kJTl2LMAmnj2CPyI2ISwQMe8NLIBLJxOLAgCD/oNCz506qlK56ncZoMuOr0MCg4pISlQpn7dY4ITEt497Tw58Z+vRwV3YoG9QQ3CCOVFJcgHgfGBIqEAghHSCFqyorrly8IJXJ+g0eUl8QLA+KjAYLTrGuVgPfL5LKcnPyln344dFTJyQS2YiRLyAqb9+66X5OFluEXBt5boYv5Au1eh10iFQqQW6g12l9vLxefOnlp55+bue2LQsWzCf3Za1WBwrL4SKRyRE96+pqbAwxRP0hf4R8wnYv/awO/WstpC5W6B2SwDgcPB6vTVLrRUuWXzx/+ovP1+Xm55stVtQ3iVickNA4IyOttrZGwOMktWyxe98hnDB2DFvPmjI5Le3eF99vxpljzV/c0CTBmXSBW1lhxodiM5gta1euuJVyffFHHykVcigzmUyM04SeRGh04fLv5xS+/srLl69cSkhI+GzF6pZJLaGCuUQEO5seCaW4GouFvOKOXApqDckK/tqagCPiACgNNARydxtHJIkfSo68GI9hmLLiorKyspysrLra2vCoqLhGjdQenrhqJIQog5spqatXrbxw/nzz5i179OjRomVL/6BAFAkkJvaJksFWjMlUh8RRU1dZUaHRalEaZSXFOk1dgJ9/x27dwyIjIazEEikOSYqAXDdpdOWlpchDsAmaqs1irdViD9rSoqLSkmKtRgNhpVAqeQIBpFZISGhUdFRis2bIlonI5fNgGcZolkhE0B9QaaQKclyg5NHQDHoDrhoyXFdX5xwMkJeTu33T97icp58fBVGO42N1tmxggN+rXR4V0I5WuwvqHgx57PChDWtWpqWnd+vSZeCgAd179UL5WxgzMgqJWEYGftmIu4NZb6amVJSVIwkxGgwoUpPZLBAJUaBICNUe6vi4+IjoGHxC9s8WAIxCHiVGbkQaKJnhDtWGhxYtJJK6phrpZJWNjL+3FxcX5eUX6JC7OuwV5ZWF+Xl2iwXtGZZq3bZNaGhYfGKiu7sae8W+RGIR2qbFAg9M3qKPw6AW4gdyFkWPE8W3aI84IpQ3rgV/VZWXf//d94cPH+7dt/+QoU96+vrqtRp2mITRYbOKpVJNbd26Vat8/f0GDnkC+5HLZajP5Br+MlAmyKmQJQgFgounTx0/dnzOog/YKSDFpFVZyIwov8jxfgVcb/0ShUL5H/IIRDDcKKj/A7BzQyJowV8gGmamp9Vq6iKi46CEoGjPnTn94eLFmfezGYuVlSnkgSexVAIP1L9nz1Xr17vKhVwXa3WNTqz0QPDC/rCTs6fOLPt48f2cnJraGrFIEhYSHhgU7OPje/7cqZu3bkBAsbvCMYn7BvCWdmcX7wNuE4tYg5wr658iIqIqKsq8Pb3gku/n3A/w9a/T1H71zZaKsuKlH35w995dbMI+zuOidlcPGTRk5KjRrq4KVzeV2t1NIMB+SO+yzWrn8QTkjrlQkHnvXl5OTo9+/ZyHc4J1QP0fDRUoTIaxcPn8Dxcu3LTpB+ie3r37hUIoxSbg5I8dPng99dq1a1d1Oq2dlAmMTTqTSCy2MnHRUc8MHzZw4KCIyHAUbF1NzfatOz5c+mFhSSlkDArQZoP2hSHITe5fL4h/o1PIOFE+dgKBLhaJ2ia1nDltWusOHSBVKyurT504tfTjjzKzsshTkojuztmCHQ6lUrlj+65GTZtqamtkctmlc+fHjHl9y7ZdCY0b4XL4REf9R3AsaI2C3PzFC+Z26d7tqaefgRQj1fTHjl6UgM5oW7li5eyZ7/r7+K5Z93n7Th1EQgGXa+eSL4kqQMmQaOrCkSlcoSFQXgj8bPcwgdQ/0ln2kEG1J9WN7J9IXzQrLo8dI0QgzYKHv9lnpCBFCvPyLp47ZzAa27VtX1RY+N133+h0um7duie1bh2XmMDlcAvzCooLi3Jy7/P4yAFk0JBkYgKbVSKTeXt7BwQGuXt4WKwWtE3y7JVEzOfxsVuSJCChqqnVs3fS5dhSocD37A100tkPLY6kB9oUDcvZVBmLjS8UQReh5pSUFFVVVhcXFWak3TMzVrWbW5sOHUNCgrAboVgMCYKTZ6dulZI+ZJb6mmizmYxmuUJuMhlSrl47eewwjy8cNPQJv4BA0isMrSwmU7k1ZFA9zBbb+TPnP1m+1GQwPDtyZJvWrYNDggQCHmPUF+Zk389IL62oNJisAr5A7emJH7RTi8mMfF3t4QHdK5aQrnoUBiobkhdStvBLMPkDU3oBkpg+CP76qWTYZasLlyQxD2AhUwIbpTLy4vryshKbhcm+n3Xx3PmcvBxXhQKVITo2ztvbJywiHEeEIIbdYRq0RyhHWAdeF6dBjPUjMBq+MhmZiqraLzd+cebM6Z59+gwf/oyHl4eA64LKgggiEIpLios//mDR/A8/kkqlrLX/WhOi2ZgZM5oJmtH0ieP7DhjYuUfP//qgbJChUCj/axrAG+NIxx4ZbmhmGERfX/9AV5U7/CCyeZFY4unpee/O7bz8fNJbxHGBUrbbrfDX8DRvjh2fmJhgZcxC9k28QrEU+0KwRF7uFxiUfvfuufNnTUYTAi2y8/Ydu0BWnccnZhPxjqSjyIKDkzDADnQj54HfD3gw/EUORIKxVSqRuKs9SkuK5RJ585ZtEL2rq6vHjp3QrXu3Js0aDxo82NNNBd1nMDHYTm/Q3bp96/CBfRWlxb7e3io3lURK3i1HxIbNIRCKcEhofpWbO76SyuX1x2MhJ/EX++4/D07QwjAlBfntOnUaMWp0dFR0ZmbGyZPHDh7cez8rQ6vV5OTcLyoqspDJnqFcWGFlQ67lULu5jx07bsy48QoleXJFr9Oq3DwSmzZt0rjprRsp5RWVMB+SBJJ7sJZAbP2VH3IeP5qM/CJxlAwHhNnclMrnnxsxe+7c+EYJCKjQUnKla2h4RIdO3Qw6bWZGBrE+mVbCznNxGI0GXx/fDp06rvhk+cG9e54eMSI1JSX56qXOXXsg0EmEELV2Lsfxb39wXLuDg1QH4nv7ls0tW7Vyd3cjp8WeF35wIRarvaK86tLFc0iq+vTpExEZhW/IBRJti8jHNRrMMqVKKJKa0QYYK5IBlAC5KhYcxXl9DxejwQjdCdNAzlrMDCok2hUO5JREAj4Z/m7Q6wxaHcrK3UPduHnzyvKyyZPf2fjVFzU1VU8+8cTQYcNDI8JR5pCzPCFf6eqa2LRZo8ZNo+MSImJiQiOjImPiYuIb+fgHiCQS0kksgFAR8wVCiH8b0To85FFajQ5foCg0Gm1RXsHFc2ezM7MsFqKesTqxKZ9Pklv2xgLWJ4/DCriQejKZxNvbK8DfLyo6qnVSUvsOHcIjw4rzck6fOrFrx46Ua1dsdhelQu6qUkGmQDSjyFlljz9IL7vVaiO+Qij08fVr2brdjdTrCxcskIhFMTFxYjI64m/QCu9n3Z8+dcrFSxcT4xPCQkPjEhqxQ3fI3Qylq7t/cGh0fKNmSW0Sm7WMiIoODA728PL2DQh0V3tKpDLkN/BssB2UMf7F3tg/BCid+t07qyhbk+txNreflsnv+u+RJj74A8fJdbEjGRSgVijR1qXhEeFdunXt3bt3586do2NjSosKkXgcObDv4L49UMlk8ADx4Tyj0Yi6hCyItdGDwF3b9XoDGlr7Tp1DQsPWrFqxZdN3gb5+0THRtVU1CqUKZ47r8vfz/2jR+1269/jF0J2/AuzfbDbXVFVeOn8Ozv2JZ557sNn+URp+haNQ/pE0jNcmIyjaSI9FdWUlPDjCJXwKQqDzjlJaetq58xegD9iOXkQuh0gq8/HyjAwLa922Dd/FLhAhZJNICaWF6M3KWltQcHBBfg72BSkGKXPlyoWLF88jBEZHx/bvP1SjqYWu9fH2xu7geeH+68+E1S/1/oid8Sc8jLwzCafEmEwhwWHpGXfv3LlVVlbSp1fvyVOnSaUi0rMl4sfHx2pra++lZ2BvkLmuCkVSy6R27ds3bdnSw9MDl2OxmEmPKAnBfIPegEsTS6US2S+nhvjX0Rsw0LRGg8HLx0cmk1nM5qiY6O69eg994sl+/Qfi6vLyspOvXTOT2R6c9/SJXkV4gKxq2aLl+AkT1e4qXD7HxSEjsylzGIslMDB4yJPDxTxBfl5unUaDkq/fDEXxn3/ICqzF2P9cYFypRIzdtmnV8v33F7306sse7m6oClabHaGevApLq7935+bNGyk1tTXBQcGDBgx5evjw1199raq0pKSstP+gQVqN5sMPlyTEJ/Tp02/1mtWREZFBwUFiIY+8+gMmJB23yL5wWHaZjG8mp2Ajr92yy6XS48eOog43Skx0SihiRbIVVuWovb0z0u5dvXKFMZsHDXkCV42tbDYH9LHJbDVb7EsWLLxy6bJSqSovK3Nzd0flxx7Yq/vxKh82ED3Yaeq1q9998fnJY+T9i7m5ubdv3rhy/vy50yfPnDx5eN+eyxcuVNdUIRkViyWo5Z5QnZ4ebdu3fW/GrOZJSe6enuy4AZIKiCRipUqFmo/TZXtsyaRX+Ja9D0DSTHxkZiwGvYnkug6iR/Gn0WiGHXGxkLwqd3cvX7+I2PiQiEhXN3ci0LEvVqnhENgD7GhlbEgJSF87Shila7VYLQz0ExqhWCx0d1dHx8a1btehZ59+rdu2K8zP2751y6G9e3BFWNfbx8dhc0FWLBQTbS2ClOZybFYrilan0XTs2kVTW7Ns+Sdmg6FJ02YS8r6D+oJqqHAqKyo81B7IKke+9FLzVq1gUalcxuHyrcg3kTsIYTKJs47ZyXv44OT4MCK0Lhkgj2IVIHuxI9+AFTQavQkVEV6YDHuwWaw2BmqUHSrDkBdbWNCc0U7xg6/Ie4yQ0xLTc4lPY296kISQ/SFPBDPkThesZLdh0QRBzA4zcTjHdYv43ODgoI6dOvQZ0L9D+3ZCPj8lJWXTt98cP3YMQtjHz59NQsgGTk+IGoTU0Gy2SKRSoo95fE9Pz169eu3avm3Xrl1enp6JzZo7XOw6rUYmlxNN77ChMsfExZFC+nEnfxFo5ZlpaRDB46ZMRQ3/cTjNf0PDd/sUyj+SRzMmmJUtpAPYGSGd9yrxOdEX7MMxRqMJARVu2GQyHDqwf/eO3WmZ9zOzM7ES0bg2G/TrG6+89uZbbyKiCfkuXL7IhQchS3ovoKDwo9frDQbjpInjc7LuQ+Ig9uJgand106YtNZo6Z1w/ffp4eWU59oiTgQvDb5yDCPFeKNRptXwIOoHAarPinCwMI5VKzUYy8TAi8FNDn5z63szg4EARuW0KMUTkkYWxP/P0iENHjpHZ2Vwc8bExoSGhDGOaPmtmSFCQu1pF4hCfdMCwZVAPonJJUZG3rw++4oG/wythnUKwfhFX7uAi+tVU18BkQpE45Vry2+PHFhYVmSwWrU6HOIqCxbVjzbjo6A2ffxkTG4kIicSC1AFSDRDnSKgzmZiqyoptmzZt3bY5PSPTZCGB2A7bskmRzcpweQLnUcnRsUSehecpFK6wIOoJNFCzpk2fe/a57j27C3jsE408XklxcXZ2zonjx+7cug3hFR/fqFPX7rFx8a7u7k6FKpOKz505gxNetXp9QuPE119+QafTf/P9pumTJxUUFn79w/euCilyLBwSuh8VA7UIok2v12FzmKuioqqktNLTx8fDw6Mwv8Bus4ZGhCIvQuVBKUGiAYPZxhdJd2zZPH78GJztuvUbIRn2795VVFxSW1sDrYZ1KioroNRbN28xcOjQl15+WSoV81iR/2NRO7vl/kKI0PyxcJ3YbDZtXV1lRfnFixegknv27tuj30CJhDzkhK/Ylmg3ovoaTUUF+ZUVZRUVlffu3SsvryguKiIPhpIi4EIMoamjnJF41FRXe3l5FBYVs/eRTajrKCiT2Yy9YWXsDXJWLpPhTHgcjtrdPSAgEImip5c3clGoPR9vH4VK5evr5apUSKQSMrUhjyeVytkmQ95RwuFyINJIL7JUikPgQ6yCNl1cWJielnbt0kWUcJNmzcIjozw8PbE+6hCO6zy684bFjClTNm/d8sywYTPmzFGwz/WTPZArRU37vYM7/2eY2fQJlQfnhsJGag2liMvGckV55Z3bt2qrKtAu7udkl1dU4PqQ9tsccFMMWimXx4WuRMngK0g3MnafFAVpqjAELhlKVyKWsO8Md+iNBpSEVEzml0Rpw0AKubxjh05BwSEiAYzIr66qcFerPT29kRh7eXlyOTyJXIZmW1td4x/ojxKESIXXRs2BNoddcDjsB6aBmSCskRIhj6mtqb17+9a923dqqytd3dyatmgZHhnpfAkOXDMqC+lm5roQ1a7XyZXK40eOTH93amFJySfLPx327DP6uhqFqytjMldUlC+cPeu9efNdXV0h+klJkbfeSB+WyCSRgmT1xKGVl5W++/aEfgMHDn7yKTQEmeJnt/X+EL+ICxQK5X/DIxDB5BkI8l4DuBHiFUmkIWGeQAIXnDtj0esMkKlwnFjtyuXL7y9cOGvuohnTJl+4fAkbYa3IsPAxY956ftRzIgGnurTA09+fBxFMuuxYEezC0ekMcN8MY/nqy43ffPWVUCDMycsTCIXYudVqkUulbm7uObm5OByUjYe7ular5fE41dXV8NCQXfCbfJGY3BQmJ8o1GoyBQSHFhXlKuWzSxMmvvPG6gI//uNCtrAgmJw5RtHP3/pdfekGj1UGzvTT6xdnzF1gt5u+//lKplA8cPMjb15vc6+c8KHM5hXl5W7795oVXX0PYgILEfpy9IA0Z9nrJ8AbEAvIXfjhco8mMq0OBIxivX7Nq2SefVNfWklnN2MtB6UBOdOrY6Ztvvle5KWxWCzuVUn1cIn1+7COJOo3WVUUeWsrNyfv6668vX7mann6vrq6OjICxO3gCHnkvsZ086oNN+TwexJCnp09io8S+/QZ07NzFy4tI25qqyvzc7G1bt5w8eVImlbZv137g4CERkZFSmRyqTu6qFItEeoMemqC8rBIf6nTa6VMm5+XlHDx+urS4aEC/3vMXLmrcpMlzTw978YWXh48cCcEExaBwVWi1Om1dbUlxyfnTp9Lu3c3OyUnLSDeazUktW02Z8m7H7t0MWp1UJoEEtzBm5D+oBtBqDq7IyNjKy8pGPzf8xu3b0NAWK1Iy0heLb0mnmp0MZbaaTTyBMCI09MjJU5ASEMEkRyD5FSlnVGm2qP4qsP9fiGC9TotyJqJfKNDU1qUkJzdqnmQwGAoLC2/fuHn5wtms7GwkA0qF0j8gIDo6GhW7urI8IirGbGY+W7Gse7ceEyZNKy4quHrl8ulTx+/evQtXs/jD5VUV5c1aJi1ZNK9dxy7duvfYt2vH/r075QrXAQMGffjxkuaJTYc8NQxtNvVmKp8vDA0KyivMh7twc3MzmyCYGXc3VYCfn79fQGBIKBknatAj0cIHLdu0DQ4JUSqgk109PNSodahdyJZRvHVVNdIf1cn9zPQ9O7abTKZ+g4bExceT+XXZ/lGdRocC1tTWTJ86+eatW4sXf9CjV2+TyYivkC2j9rJWaFgYDOaiouLMjMzt27akpt6AmvTw9EJLzMi4h+oaEBhsMZtdlcq+/QYe2L+nsLhAJpXNnLuwcZPGJSXF165cRrJ65erl0rLSIQMGx8U3qq6uCgoJXbnik8TExmMnTMrISN+w+rOK6mqVyk0mk6WmJgcGBicmNikoLLh58wbqBcrX29MbuQ1KxqjXo5qiPXp7e3fr2qNlUluU2uVzp/U6na+fb3h4OLSsl5+fys0VSaASPyoFW/lJdkRMZDXz2bstsJdziC3q1fkzZ86dOhUUHNS1Z++g8EjIYKhMHscul0vJg3JcDirDpfMXx4x5A5Vn48YvI6PC4ZJRHaQyxaZvvv58/fpdBw6YDEYoYzaRIX4ee3YW3X8HSZRYnAELLXzB7FnId8dPmozrRXBBZXKu+V9ARTCF8kh4ND3BAP6O3F2zkvd5kttY7NMYzlBjtdk1Gi0W7t66dWjfHje1R3Fx+cUrl5et2PD2uNdTUq5BLYUEBzdvlPjRso+lYq4rcankWQqnGmNv0pH+RavVbjAYIXpLSssWzZ93+OgRxmqNioyqrKyoKC9r3aqd2sMz635WcUmhr7cPY7P5+PpfTb7CTmVKRpHCJ3MhrB12EbnhKg4NCmnWOO69OfPc3dzJvVS26EQiYb2CdxDB/u13W15/9SXobHj6pUs/GfLkExDBYonYoNNMnfh223ZtR73wokD44EtfObU11cmXLiW1awcFTO7lkc+cXzVcyCU7mPpF4rtJ4oGiRnEZjUaDzrBh3bq1GzbUaOpI9xqRr6R8kPA0a9Lkq6++CQr2h0AhMcm5C+f12u2QhkgsoI/xl81u5/CENruLpk5DXq6rqauqriwtKYbIhnUUQOlKHvDx8hGIhFyOHer5Rmrq8SOHL144h6rQuk3bQYMGNW+VRO6gW22oYIibUFEwmdlkLC4szM7Kys7MPHP2bEl5BbIjnKdGq509a86Ed6ZsXLt244Z1X323CYJp8tQpixYvk8hkRw4dLC4suHP7Zn5BHmqR3WbhkBonhNgl0dyF06Jp0+kzZnfo3Mlus0ok5MkthHSDTosTM9tclG7uVZXVHy/54PMvv7BYGC65Jc3aGRkRW4FIxySZcYLbp2ffVes/91QreVxkGLYHRPBfGyP/vwhGKgIpibOtran5Yv3aH37YnJNfYLORKeqCA4PlMinOud+Awb369/P28dm7a+f1a8kjRo328PQ8fGD/4g8WDBwwKMA/6NzFs3dupzZv1jI3N7e0vGz959917NwRR+vRsY1MJn9z7IQWrVt//MHCe2lpHy777OlhQyJCwwYMHgLPcPDQftSlO3fvwl6oY7ExMXy+4O7d27B8xw5dIcvc1Z5bt/2AXVkYBmmSBY1RKCK6ym5Vu7o2Sojv3K1HfFycl7d3UEgID/mZQIArgqgXw2VweUcP7j+0f3/XHr2ioiJDwiNgSkgoHGvvzp0LF85v3bLV/EWL0O6RI6GiIg9mrdCwyLmfc/bUKa3eUJhfAEvFJDa5eP785SuXb9+95ebuERwUgkY36vkXgoNDp0wel56R1qpFq6nTZyL3mjDuzYry0qZNmtfV1dzPzXli8BPvzpzjpna/fuXymNdfbdS48aR3piOJKyoq2Pj52lat2/r4+n2waF7z5q0mTn43N+f+qk+X12o0MnZ24fSMdJwJjhUUFHLh8gWpVKKQK/r1GbR1+/eDBz+1f/9uxsJACqMMkZ/wuTyDyQin7+3lFRIc2rRFq0aJjYOCQiPC/eVSYjtnYmzQ601Go0Qmhb2MBmPa3bunT53RGYxNmzWLi4vx8/ORy0QQxFyekMMXLn7/g09XrXhi0KBlyz+GQ0BYcfZnr1/xWU1NzYQpU+FUUQ5IdpxS+M/gzNXRwBEd4Exu3Ug9fujQa2Pf8vbz12k1Urmc/yduF1ARTKE8Eh6BCHbOO4b0nzGb9Trt0YOHGjdrFhYZJZZILBaLyWQSiyVZmRmffbIcInnAgEH3bt0USOQyuWtJccHEd6c/8+SQE6dOqd3cOrVrC8miVqt8fbykUuGPU83ClZBuM7MZWoqMZyAdQg4XnYHJysza9P03Vy5fKisrqamrg5JGGEYsNxpJF5NSqfTxDcjKyqjT1illCvJWDjI6ma+Qyz3Unu07dJ7y7nt+XkpyP47oY9I9Bn2MBQcZJwrgIPlffbdl3Ftj4IgD/f1atGr94ksvQ4fBX54+cWzdqpXeXp7zF30QHBLEnicLuavvwBmyYxPJbhCtnd80ZIgys0MEo5gh/3DCPIaxMVaHwWi6euXahnVrjp84pmeHjmBlpwbmcngosS6dOi9dujw0NIDjsEGVkF4f5w5/HN8L4UhW5pJ3iaFcbFYHYhq0CNZAEeFzWApVhHQj8XiVVTXnz509eeJ4Rnq6VCJp3rJVm7btGjdt6urqbmYYHI6dshf742i12qOHDt+4eaOmsiIlJTktIxNVC9+RukEeBRNwOQ4fbyRB/us3fi0UCF99eVREaPiMuQteHj0yOSUZilxbV8sOcSYG5/H5ZOAkub2L8+CikgCE2KRWrWfMnhebkKDTGfJycw7u23X+7Omqqsqq6hpUIZWbm4eHx4FDh0h3EntrGAvOGgB9hjQC0jkyIuKtt8Y/9fTTpK+L7Qb+sWo9/OEQrFqwQmiaTWb8SQ5mt/N5fJLfIMYbkTDYeXweSuXzNatXr11bVVOLc8C1o7WQ2zdEH1vQLBs3bhwXExcYFFxUXFRSVpadnXXjRirKVuWq8vXze+aZZxUK11PHj12+cjEiKnrRkmV+/r4QbZ8uW3LpyuXPVq4ND48Y0LdnYnyCp4dnUXkZiiv93r1p02eVlhSVl5Zt3voDWme7dh2iYmIaxTXas3tnRWWF2sunbftOqdeunL94plOHrmGh4WdOH0dhanXa8PDIjIw0WB4FWMcOdOVzORKpJAytLiy8RbPmsQlNIqPC4WokErHZzORlZ9+4fqWkuKhbz96xsXEWixlp7ZpPl584cXLJhx9GxcZCHGPPyFMa4HAIJCTsuALyVraq6jpUuQvnz/n4B2Sm3Vv+6SdwaM2atjhz7oxGqxGwMy43TmyCK/Xw8m7UuLlIIKysKDt1+oRBr3nt1dfHvP0O8vbN3323evVnlRWViz/6qE//IV9uXP/pxx8Of3okvOjWLT+IxaKi4sL27Tu2atX2wsVzcoVy397dKBm12kMilc2Zv2jpBwvKystxFFSMzl16ILFbvOR9F5tl/Lgpqdcv3753G2pYp9eNHPXSju1buByuTqvloOHBPTjsQQEBTZs1haEjwiOSk6/k5GRXlJeTB2ddXcl81QajwWRGs4HTFolEXvCknl6RkZEt27RDYz+4f1/a7ZtDnxjcpkNHtC2SRZP5wx1rV6zo0LVbZHQ0WidjYhRKMgdFfdn9l7AOzUamPqyqrNyy6YennxuBSm5m34+DFg2c6/0XUBFMoTwSHoEIhsyFB8QCkmk4wZNHjuzdv2/c2xMRR+vqND7+fnCOp48ejW2UGBoeBp0Bj1OYX3zu9KnSstJz586uWrN+wdxZP2ze7OPjPXnS1PjExEaNG4uFLjIp39m35uIgOpjVDT+6FYejoKiYzxdJ5YqykrLKyvJTx46cPHUyLSMdrgteFVKmtLISHlZIXgDLqNxUEB7RUdFdunYf/NQwLy9vM2OTCDkqheTH3gQiX+CUTSaj2WCQuyrhXqura9+fT7r6IOCaN2mKyOnC5YkkUjdXV6NBZ2Eg6Ac+M/I5lavCuYu/L6wIJsqJdANzIJt4Zottwbz533z7XXlFOeQrBGhIYFBRSbFGoyGj53gCxCahUBQa4D937vw+fXubjTpXt5+9ie03YcMbmcJWJBaVFBfPfHdqetb9jh07Pzn8GW9fMsmrq0rFJzPFkplGsHZtTU1RQf6BPbtPnz6dlZOD8Ex0JHn3Nc9VpVQqFCGB/rHRMTK56qkRo1UqObZ6YmD/pDbtp86YnZWWPuK5p9zd3bS1dSWVVYxJz54qaiuZvAzyIjwsLCQoJCw0JCo6rnGzliq125mTJ+fMeo8nFPbp1ffoiSNZmek2u4MrFELoOqw2hHkIkdDgkOra2oqKcrb+uLi5uQ8Z/CTkQpC/p5enysPTS65QQD5CnZJJAP9iLBZkoSaDXo9cFOeIhK6ysuLuzRuQnjiN2EaNvHx8oM7d1R5CoVCnqcOFGBirRCy12MijVA6OgzEaURSwLtLUlORrV69dk0llKHaoz+YtkoY88aTJrJ83Zw7EZYvmLfbu2zt33gJkPkGhwUgjh/bvHRfXaMmy5evXrMrNyvIJCs7LyuzUudsXX3/1/MjnoYwuXbo0cPDQGTOm3Uu79+70maXFha5yBZTHkWNHu3Tp3rpt+/XrVyOrGTXqJeQPx44djomOuXD5Yt8+/W/eSEFNSLmZ6uvlk9AoEdXmxs3UuQsWL5jzHhRYdXU1hL7K3b1Jo8TBQ59s3a6tl6cXBMz99DSrlQkLD3dzU6WkXJ8/a9b06e+1SEpCrYDKxE7+fD/iwwenRfyQHXUeeYvRhHQGxmRGP//c7Tt3g4KDy8qQVFRzuES+c3ncFk2buavUvQYMbJHU+sKZs/nZ969du/jyq68OGvKElQyM5laWV3y0aAHyzOUrV+fn5MyfOycuoVFdZSX8ZOcuXWtq63QaTc/efaCqz505xRUIv/zicyQTY94Ydzft7guvvHp03/4TZ06JuByDyfTD1j1TJ409fuY0Tu/QsXMLZk2rqa4KDYs4fur44AGDi0tLbRampLQEztrPL8BVgVrEDfAPNDMmLy8vCF/nE64597OQqzRu1jw6vhFySIFIYmHIg4xIcawWJvnKta1bvr99545cJuvapfNTw5/2DwxE2gZ/jvzNYrGdOHr41vXkce9MQcYqlUnIKP0/Bxmc7HBAmmP/UNhWu23arJ89Vk5FMIXyt+MRiGD4aUgKxBaLhREIicPaD6Vy6uTrY8eFhIVDbJjIU3FCJPRwOpUV5dAxmzZtwWoqlap50+YFJcUr1qx9Z8L47zd93693n9fGjG/cJFGplPK4zjvMrKcjGuNfPgVh0mSBJoGK4ZGgYXcYjSZENRt56Sh5PlqulCEG6MgL4Uh/mBSCmk9GC+I8Geg7u1UsErPj0EifUP1OXTgmo7G6slLp6mq1OU4ePXL9+vVTp88olMreffp179XHVeUKZSFXqHAgoZBvNBiFQoFYJPgTDxA3FIgIdlhIKbPdwEg26mq17y9aVFNTC72778BeCE2JWJSY2CQt7d69rEz4dxQyF0Vrs44cMWrJR0s81e6sAP6pMH8bBHytRkOerBEIJo5/637W/QUffIhMCVHfYrWUl5ZcOHcOQvPShfPJydeqqiprNFo+j+emUrm5qwOCQ/x8/X18Atp17ukf6CeXCV2sTGVZcUV5aUZ6BmRfQUHBzZs3K2qqS8vKx7/1tn9A0JIPF5WWl5H6aUVyxERHRvXu3adbj97NWrWSCEVC8p5dDgO9YGIcZHov8mT6119+8dFHi1GlcEpmCxlOg//4QqELOzkuj8tp26Z9cUnJ3Xt3UZeaJDb9dPWGqNgobZ3Oqq9TykUKlYpIbTIvL5kUpf6y/zLQuEhfOC6D7WW32ayo/Hqt1plmyBVKkqPCRqSrm3Ss3kxJ3b//QERMTFR0tF9gEKQktKxEKsXKyBvRWFBM2GdpcYmFMYdGRpw9eXLzD98/+9yI1u07ov5XV9Xu3rHN29OjZdt2udlZednZIeGRufcz1R6ebTp0mDLhrcnvzSwvKf1w0cK5HyxZt2rlkSOH58yaJ5ZI8vJztm7eBIHXvHlLTw+Pg0eOjHlrQs/evW+kXJ81Y5qryn3408++v3BuXHRseWWlQqF497253321obSsBFLsxVfGXDl36vipEz179kFL/+6Hb8xmMxnoz+UG+fsz7OQzuPZ3Jk/p3afPudMnTx4/tnDxIuRLH8ybP/ndadExsUgPJFIZW2B/oK7+j4B/IXdZWC3M3tNAS0TlcTg4586cXLRwAS7W1y8o+epl+D0vby93V7dGjRvv3Lmja9duCxYvYUxMdVUlKgJ8V4fOXULDIzesXf3lFxtbtGz5wUcfX79yBdla85atvli3dsCQJ3CgebNnvDtjlqfa4+jhA9euXZ00edo7E8cj7ZTKFN379OFzhd4enu9/MD8nN2fevIUjR7+8YvnSlas+02jqDh87tXzpkuSrV/r16X/s5DGFq2uHdh0uXroQHhF1YP/uJo2bvT1p+jdfrj9x+jiaiV6ni4+LXbrss1ZJrQw6TXF+HiqkRqNLuXHjbto9o95A+oxbtvLz8wsODZXJFAaDic/jFhcVLv1wUXFh/vT3ZuFblIdCKc/Nyl40f864SZNjE+LJraOfzQL/h0FcQIsQiqDOXQrz81d/9smLr7wWHh1V/zULFcEUyt+ORyCCidAks8a68Ph8CGI4Jw6Xn5mWdv7cGThTN5U7AjNWEInFdbU1B/ftycnJPX3qTFKbtgF+/ouXfijk8RPiE5avXH1g/745s99rltj405VrAkJDoI0QsxEP8JvcriVuhRyOjA6Gp3fhkNmCyAN5pDMPYdtqseIEEEecs6pZLSaJCIGcwfnghCDXOMRvkkl9iC6xWBBRpAoFu394K5SbS3Zm5v49e06fPXszNdXLy/vNsWP6DhgkkUhtpGvGvuW77y5cuujmpmoUn9CtZ29ffz9sy+dC/ZOz+lvDFjMZ08LqAjIg2MHhFuQXbvrm202bf8jOy4cwIrekubyKqko7x8XDw6u2rha2FvB4QgF/QN/+b0+cFBcfKxA6DeW02m9EKKxjg8kExEavvfqqTqtb9ukKhcrt+JFDa1augHCBoAkPjwgODo6NTwgIDPT29vH09DAa9DYX7tXLV3PzciuqqnJz84sK8vNyMkUiYZuWLSOjImJio9Vuav+AAB+/AL5IumHNmmWfLu/Vc8CW7T+wqo48NW8xmyDol3+2OjY+FssZ9+6lXr9WVlaSn5efm5sD7SWTK8a//c6AQUO+++qL99+fX1NbS3SyUOTv69e7T//OXbp4eHpKpTIvH/+5s6atW7sKhdO3V7+PV66RKeRERgg5Rp0GkdViZtxRWL4+IudT7X8ldTU1OEWxVIbIDSEI8QQJS2SV3U7Gh7CjYAUCodFogEwWSaQ1VdUXLl5ctXLlteTkwMCAzp279OzVu3nLJDQTAdYTkLctYCdmg9HVzY0oBjMksshkMkO4oCikMgkaHSqMTqOBskTq+N2XX+h12lfefAspwycfLhk3adKZ06e3ff/9jLnzGbMJZdi0eXMul5ebkz3zveldOnWOiYtv1aYN0uO0tLQVy5aNHP3CqeNHle5uzZu2XP7xh14+3s+OeH7GtKlPP/NcoybNP1+3avATw6ZPmzJr5tzjxw4fOnxw+vTZa9esyM7LbRyf4KH2vHXnZnhomEwi8QkMOHXq5KgRI94YO+b92bNGvTCayxf88PU3Y9+e6OXj43REKIp6b9KQcJ4QaYpsfo8zNJpMBoMBn5gtlprKKh8fX2SeEPFCkQAr1dXWZWSkBwUGIi1kJ2fgZGdmXb50KalNO29/P7vVBluLJdLM9LQvP18/YtSLTZu3WDRvdnlF5ez5Cwrycnds3vT6uPE3rqfMmz87ODRi9eo1iB0arXZAv75t2rQrKSmZPv29jMwMT0/P0LCIKxfOP/fSS1+vWzt91oyxb4yJiIufNH5sTHRM+3btt27fOnLk6HYdOn+6bMnzL7wkkysXzJ11685tm83iHB817Mlhcxcs9PL0MJuMSqUC18U+b8AnaRvJ2ciYqfS7d+BS8rOzc7KzBRJxUHBwp85dfP18L5w5cysltWP3brEJiQgsF06f3rt/3zuTp5LXavD/tMp0uJhMRhT25u++0dVp3nrnHdTz+q9YqAimUP52PAIR/P+x2hwms+l+esb5Mye79eoDReKMzXAxer0OUdNgtMyfNePO3btr1n+x+tOlvfoP3Llj+6p16y9fuPT6qy8iLo4ZM75X/8GBQf6MhZGKhbXVNWp3cnMcchu+njhO0k3yL4hSZuUbPif/EREGtcY+hORcj40wRBZADWN7aGiHw2KHIOaWl5ZwuYL3Jk+6d+/u/bx8b0/PQH9/6IYFHywNDwthrGaVSgnxlHrtWklxsZ9/QEh4mNrDiwSMulqlq/J/0Mn3P6C6sir5yqW4Ro09vLxRiGbGAnsJxaLiwiKGsXh5e505dWrihLeKyypQso0aNR72zPOL5s9EyMS2YqEgwNdnzZq1TZsmQgzBBDpNHRkJ8PP8AHZDMcJ8AGoJ0R5yBDFeJpOfP31qwfx5Xbr3em7UC2oPD+Qc1VXVZhMUl+nYwf3Hjx/Lyc9H0oL6A5WjclU1ada8d/8hvkFBc9979/iJo0qZfPmy5R07tXd3U0gkkJswNqoHz+4gr6KdMWXyhi+/0Op0+NBuxXWRkeV8Hq939+4B/v4nT5/y8lB37dK5R+/efv7+yHcqquumTHnHYrEs/3SlwtV16eIPSgoLFy75ECGZdLBarEIRMiNxnUYnk4o2rls79d2pUMiMxdK/d58hQ568fOn88VMn9Hqtp7tbuzZtnh0xonlSGzLw4lGDHICDa+fzbVaLRlNXVlJ2/uz5rMzMg0cO3U1PR9OA8oXR3VVu/Xr3fum11yJjYh24WAGfz/aTQ5vBInq9XiSWyGQygUhA2hYaGrvznxoZPtNpDcg5Xd1UKVevIrcJCgnxDfBHM4H5TAYjRPbZY0fv3rnzxDNPqz29BAKxFfZ2EK8F7Y2TPHPixIG9u7v36Nln8ODSopKMu3eTOnZCyaNF79m+DRqrWcuWzz41tLi02MvDs6q65tnhz9bU1IybNPWjxQtz7qc/99wIL08vN3dVyzZt7t1I8fX3LywqTM/IHPbMc2SOWx4fh0BSx2t4yeuDVQTlaXfhoGTqNHVoBlYzc/LYkSsXz7dq3nzYyOeR5MhkUng3MgUjhNqPmaeVvEXcgWvkkftTZLprXOzRA/u4Ltz23bsplIp9O3eGhod7enmvX7Xy9JnTSz76KDYhwaA3oFqIxWIUC4T16OeeDQoJ7d69R+fuvcxmk9pTfXDP3g+XLNr41bfIIjZ/83WfQU9UVZaOeO6ZIYMGT35v1osjnkXBLvpoOZp8aUnx+LfeuHsvDY4WJsM5tGja9LOVqxo1boxT5BK3Dd9d77mJ0yb+mszXjaQNFQ3XYDSaa6or0di/+mLjgQMH2rdtO2vBohnvvP3BJ58IBWIuj/vVunU4UJ8BA1xdFX8ykUHhoEpnZWUhf5s6Y4ab2hOavP67Pw0VwRTKI+HRi2C4OCMZlegC33wzNeXOjdRhz40k8zsS90KUKzz4tUuXIapy8/N37NqV1KxpZk52dXVNQlzcxq+/qygtnTlz+vlLl93V6gkT3+3Srbu7m6tCrpRJEaKxT3hO4kPJbd9fdVjsd/Xeth7WK0GH2a1WErx5vDqtuTA/b/VnyzPSMwqLizp36SaXSAYMeSI+MXHjujV2C/Pqm6+zoyAcpC/ZYbOYGSs71wFkulgsJTfk/hEgcB49eGjiO5N69+o5b+EigYg82Y0YBsWDC6+uKt+wepWrm9uIUS/q9IbS8sq3J4yPio0PCQ3/fN0K5DSQMFKJeNqkSS+98rJMIWdMJpXaw8KYyXPcD0BKnkxZiuhAshCIURSsQafF54h5BoNx3ty5V64lG/R6gUAA7RIWGtqqRYuYuPiwiEiFSgXVQt5OzOFAoNscnKuXr8ybO/vS5YsIoi+MemHugoV2i9lD7Qp9yx6NxFsYWacnQyvfnzt3y7atqA4qNxVfIOzWuetLr70uEYv9AnyRFKHK8gU81Ao+j+PgcjUGy8ULF2dMm9K3X/9xEyZCAXN5nJCQUAG0s4Cd10koMpmZyvKy1JTrX37+ea1G8+33m4ry826mptodji7du8fERCGyo37yuGRMM8MwZNaRPxmx/zRQSEhLAIrdZDSYTIxUQTKWurpaZKYwDRI/d7U7rHTp3NnTp04UFRXVVFV4q91bJiXFJDTCVrCsr4+PX2CA0lUF4xoNRqQxD/aW2W02g94oEYvMFobB/uUyXDgMjm2JqIN3skFJG5ESG/Q6qC5kGjAHkhKi3djB32yCRDJlZFOVFRVIQqDnsu+TqcGz0zPy2O7/NkmtO3Tu6k0eYDLBKDgHPo+vqUXeJS/MzVGr3d091EadzqDTqL28UOr5ebmnTpx88pnnpFIyQQEEH3vOP3cODYAH6wfxk8hFzWTiETQYM2PmcEj9LyI9uD/cuHmzWeNG7Tt3i23UCIZAA0TJQRCjDI16vcNm56JEBOybGsm0koxCKTebyD0xVHXyACiPi1wOTU/uqkK8cI4PQZLjbKGQoV9v3Nh34AA/vwDiZbk8rIOkVOXmhj90Wi2UdvKVy2dPn3xu9Ite3j5SmSwrI90/MFBXp33ppdE3UlOkEll1bQ18pUQkfmH0i+/NmoV6hat7UAQ73fgvIP4Bx+BycR5sjXCcOX5kzapV7Tp2VqtUT48ahTOsq62dOf3dF198Oalta1br/5egTpqNprKy0gVz5y7+8CM3tRqN98/s8BdQEUyhPBIaggh2QHeIJFK4Y8SnE4cPIeANemo4wo+NTBrFR6grKiy6d/teaUVZ334DxRKxTqsvKylYumRReXnFJyvXwN0v+mDBlm3bEEn5PG6/vgM/WrZMLJIK+RyZWCgSsg/MwZlyfnbr6hc4XLh29gVID+DQanU8Llcml2k1mnu37u3du+fi+fN1Ok3LpDaImgMGDdq+ZbNCpXx78rvePj48LkchFUJpQ/haGTP7PA0J8wircNTkCA4OX/QzEfA3BfGmqrr22uUr8+fNnjx1WpeuXUViES5QKBBYLAwumc9HIMS/9qtXkyeMH1ddp9MaDOMmTJVK5YsXTNfqtIi4Yj53cL8+k96Zkti8OWtrdhaIB0BUYBCKzWaZQolQevtGSmpycruOneIaJZJxtyYTXyQxma06rQYCCHpTq9WSSE5yHyIP+AK+c9iGXmdAXFy+/OM6rS4kNGzSxHcRUDd/u3HU6FEDBw1yVbk5D+cECqCirFTt6YnjY2OBUGwwkgwN0Q6KgDx4R+ZxA7hAMlGa2WK186UOF97RA3unTHq7TevWM+fMCQ+PqK2sFPB5JUWFWzZvPnP+QlZ2dkJsXP+BA6Nj4hKaNBZAoEskOo0WYVsml4uEPJQbUXV88kgfDoWcqf6EHh12q40IDLYHFMVI5oUjffMONDELY4FCgaCEIVBisDWp1fjeaoaUEghFzkpuNBiqqqpkQK5AWkua4AMj9etBs7TasDdsYjZBujmQOXDYhIfc5ydD9hkINkgxrAFvYNAboIyI/rLasAaMDnWVnpEJaylk0pCISNLtLJMjKQoKDhGjkHVaKGkUMgQilB+EOPS8RAJ1a3NVQMyhjlj1Wg0UGwofxrWYTQ4Ot65O4+XnjxaNrUjLdXHBrpzn23D4/yLYRKbE4XD5XDZ5IGPlUa4wh1gkNJnMaXfvbPn269qaarlcGRiCoooKCw3z9fF0c3eDdeCeSMLGmhvFgL1jGfKXxyfjjFHgOAYPuZ+N3C6DZubyidrGcRms7IJUk0HCif2UF5f4+PtjQ8bMwOCwmaauDopbLJEi4YRLRFaD+oOUb8XyZYcP7JfLFXfSMyqqa3Cq3bt1W7N+o0gkksnEaAU/iWD8TzqBWUP8CAe1A3WDpI48gQuXV1eng98tLSqEO9q9e/fb48YeOnEaqWZQSEh21v29u3a8M22q5M8ZEae9fdP3CoWiWcsk34AAuCZEl/rv/jRUBFMoj4QGIYIhcURiiUAohFPLv59dWVHRtGVLPunGI1LDYrGQ9wxxuAhIUMDkhB0u+/bsuXfjRo++vSeNH7/2y28CQsKOHT87efxrQj6voKgQfrZLp86ffPpZRFQUcnW9VguXLZXJEVPZ0ErupzrsLhBMzlQeAdVqZcibPvl8+F2r1aE3mBib1WQwkwcscgrffHWURCT08PDcvXfXk4MHFxSXdOvShbFYevXp687Or9m1d28fHx9EUEQOiCS9Tmc2Y1uFkJ0VmOhf0tcIJ/5g5Pq7gqiEAIsiXf7RR2tXr9y8dUdcQjxEJ+l2NTEIdQxjRtowZ/bMwsKiV159c9EHC2/evhMVFfPZ6s9z7qdNmjCupq4WshXCKiQw8KUXXx796usqNyWJpna7RCLCgtViFvIcteXlCg8PxmIvL6saMKBfXn7emtUbnnz6KWQgUqmEx3WIRCTTIHoJOYyDAx0D20GWIRhDJhlM5sLC0slvj7lw8bzFao2Jivbz8S0tK1mxak3zFi0Qw+RyKWM0QF1p6+qwCSqGXC4nUg0RiX2NCwIxqkr9ZRPILVnAhmQC/rE5yIvKEMJTr15eMH/+mQsXSIS22b083Af06fPy62+ERkZCiKBioPphn2T/D4BzZw9Y/2dDBiVMbA/Z+u8uBLBihdR2clHkT9K42MpPvnTWf1wr+yH7kbMzj1XMZEOH49jB/WXFxWSZ3bnJaMzMyDBD67Cro9G6u6vRqJFKBIWHQS1hbxJ2Jg2n7AakLrDHxZ6dH+I8YWuT0YBliVQGP0Om5SKQayErsMvkFwscBLkSdvn/X2NDBldOip61ESlpUmRsSbLmIFfELhP5CGFrsRh0uivnzp44dvRuepqQL3jm2WeHPv2MUyliLXYPWNeBddGa0LrJYHGIUxRv/e7IWljGb6drdT4MCg+IdWBWtMS6mmqZXHkz5fqRQ4du3rxRXl4plctee2NccHjYkkULlFJ5ZWXl+csXtUZDiybNP12xMi4uBpkgkb/kCGTGdxgDf5JO6Z9VJByWnAR7ni42O1dvJFNjTJ749s5dO7Nz8gb26Xnk5Cl4CXYTx4vPPTt23ISEpk0NOq2rmzsuHlshlyVf/m4KCwqWLf7gzXETfPx8EbDQotkyfjhQEUyhPBIaxJhgZ7iC44YDhSerrqzMzcoKCAzy8vODJ4Ub3bl12+Cnn1MqlQIBr7Ki6vTRw9k5OZ27dL2Xds9k0G/c+MX4SVNad+haVlT80eJ5Xbv1VMqlFy6cvZZ8ta62LjDAf/ToF+IaJXp4eqtUrnDBZJijzQE/yGefDiEn4HBYoZwEUD782pravLz88sqKsydP37xzG3/euXendas2l69efnHU83qdJjgw8Mmnn1m3ZjWfyx3yxFNxjRsb9DqFQmmzWXERErFEq6mrqawUi8VKlZtI8ui79B46iEw2YilLSWEhok5oaMj02XOsVhvkiAiinwyNsKbduXUzNeXevXsbNm4c/vSz0LsnTp6QKZSfrlhXXl42a8a0/MI8MztHB6JYRHj4a6+PDQ4O7tSli0Qs0Gl1IiFfxLeTB3pc+KkpN0c9P6pJ05Ynzpyorqp68/U3Z82bJxLyODZGLCaHQyCE9sUJmBhIcDFjJTcQ8Gdq6o05s2dcuniOJxCq3dwT4mJfH/NWdExcTVWFf0CAWu1uNhrc3FwtDGNg70Js3fRDYpMmjRITiQQmt5VJ3SDZ0q/CmCGk9dDQSHhQkVB7jUa9h4cXdsgGaiLN/15a6pFCrFm/6OTnf+JbaCIoBvwPvwF9hub868WLHRA17NxPvYJnv3jsQVEg/+ez7wYyaLWosRKZ7MHCIS2Lsdjstprq6tz72fm52chPyatn2Pe6oWlYGEt+fh4WoAghj8UicuutprautKzUZrFERUa17dgpNDLCZrPrdXp4XYFILJJICnLz0DBHjn45Lzd32bIPi4qKcOjB/QfOX7jQ18cDfpjHJwPZoH7tbHKLM+L+6n08vZGx2lzgnJ8aMsjL03PhoiVDBw+4mnLdoNF4+ni7OGz7d+3Cobv37msjzgFyk9QgnHL99r+P27dubfv++7enTJHKZDy+AGWHoqv/7k9DRTCF8khoECKYbf8ONjiR2IZPnIEQnzg5uGcvn8fv3KunUCiB702/e8/X38/ucDlyYF9CYtP7GemffLq8U7deo156RamULZwz5/ixw1MmT+0/eKCuVlNcnF9SXKI3GKurq8uKiyGpXRwu8NRWm81IBiJacDyxUOCuUoUEByPAypWu3j4+QSFhIql0/qxZNbU1mRkZRaXFer1h0by5Xl6erdt32LN9a99Bg81GI7yhf2AQzhBRFgj4vIqy0pzMTHweGROLiIJLYS/xHwV0iNWG+GeF+tfptS+NHj106NAXXnnF4UJmnZNIxbChyWQqyM19d8qU7OzsTl265uTmnT1/1mGzDx7y5JyFi7KzcqZNmXDn7m1nHIIMhRr2UKu7dury+pgxzVu15HFc7BYjotexIycmT30X8XLYcyMG9++Xln5XyBcMGjBw8dKlnmo3rIRQBslK4qXdgeh78tjxM+fO3c/Mys7OKi4rNZvNQoGgZ88+Ij6/TlMbEOCPY02fMUsul8kVcuhWZ8i3Muap77wjEonmL1okEAh+vwhGRUWAxybk/ryFwZ/YEtuS3kT2W6g06GMiwih/HLYAyYj8+r/hE6DIyGxuDugwATIhdlhw/Xf/ASKXUV2tViyTOUvIQ3v/wFb5X8BWWguSN4hg0tfL5UDVPdg/isLXajQikRgfYlmnqUMrU7qpfhTB5F02+Aq13cyYuaRXXor6jw9hEhQxVsBXzgcl8TeZkZIMMrbPnjFTJBB07dFr3Ng3MzIzYKLwsPDx4ycOfXKoXAon6iIij1H+ARHMWB0mxpp8NXnIoH5jX31tysxZL4989r3Zs6Kio1FlNNVVBUXFt1JvPDtqNBqjmbwNW4yLrd/494ELuXTxYkpKymuvvY5GLSC3+Ehjr//6T0NFMIXySGgQIpgMeGClA07GqNcbjUYenyeVyBDk4BogMTVa7ZsvvgDx5OHtA3/qHKSbn50TGEpuid69fWvy5HeuXkseMHDIkqVLVSrV1m+/Xfrx4k7tOsycN9fP399BHnwm7/cighqahtxOc0C44NDw1/gNhY0YaTCYIIzgcTUa/f20tFWrVyDknrlwIcDHe8q7MzesXaFyd39v5kwLYw4ODavTaCCC1Z6eCCG11VVCodBV5VZZVnL35g212gMKWCiRIAiQUZ7/OBCWyOuLhULERcSDQ/sPLlm04J3JU7v17IlClivlWo3WoNMpVaq6ujoen//NV1+9/8H7MCu5keri0n/AoE9WbygvLR73xut3bt/o33dgsxatLl84c/HyhYLCApFQ5OHpFRUW0rZls1GvvPLaq6+5uXm9v/RTvkgy+tmnzl88J+ALsM9Af/+IEKQfVp1WV1NXp9FqGMYaHBgYFhZeXFycevu2Tq9HlUpIaDRl2owDe3caTcYhg4fu3LopMTHxuVGj/f39SkuKvb19UJGkMumyxR9AHL05YSLpvkWrIL1Ev7cnGIFdU1drtVixH6hnVDGIBkRHLNjYSdZEYtFDDJb/dH4pTVCM9Uss+BN2cQo1pwiDmvl1HYzvUA+L8vJQOQNCguXsRIf13z3eEHfocEESaWW1LAoTJUMm1XkApzhzlhiraQnO3AMLaP+k6FlBjA9hC+SETgPhN3ao12lFIgk2ttscdjLOmJ927957UyZPn7MwPDJy+FNDL166gJ2OHDn6w4+X261GlVLGsVn4Qj4ZPv67RbDNwamq0Qzp26u8ojz5xm2TwbTl6y8Zm2nMhInauhq1h8fl8+fu38956plnSCczSXHJoHNcUP32vwMEqVNHj+bk5T3/wgsmk1EmU8Dn/6Zz+P1QEUyhPBIahAj+BXBPrIf6FxaL4+KZM1q9vmffPga9ATIL0kcmk50/derbb76C3MnLL+zcrfexowfLKyomTZz87MgR+bk5Kz/52M/Pd/zESRKJhB0FzIFMgX6C4zYYjFaGIbf/JGIoHiKN7S5Wm91oYooKCnZt37Jn907E1ri4uJDg4LHjJ+zetmXky6/s27k9Pzt75KuvSsnUmyK4Rfh6+FOz2VRWUlJbWekX4I9jQR0CHt95p+wP+Nm/Cygrg9EslpDeFLPZUl5auuKT5bW1NfPe/wCpBUIhgiESGFy52cScPHJ47do1ZRUVBYWFrq6uLhxeVVVlh/YdZ85b5OLC+3LD6i+/Wq9yde3YruPgIUOjoqMkMnnypfO3b94oKyvlCwS79u4bNHDQ+Cnv7di+a/u2H+7eveWuUiG4xsbFzZw5O8DPB6FSqlCwE6U5Dh88uPzjpRUVFTiDsvJy2K5xo0R89dTTz6hclYUFBYEBfiKhIDA4EEIaJkcIg36eNXWqRCabu3AhpIASZ0hp2DidA/kNDYJ/7HYyJQIrU6wW8giXUCxC69PU1sDiZKaIwgKZVNaoSZOEJk3RNiHLZHK5c1eU/wEW8opxIrJNZitfwP9g/nwzYxszYcLFcxcXLZp36/YNhULx8bJVvfv243MdSrnIYtRK5DLkob8qgjnkMWh2dmq7zerg8A8eODRs+JNJzZvvOXRUyOft37HtWmrKezPek0glQgE/My19x5YtL7z2utJVBaePbbFTxIL6nf0O9HrdsX37IqJjYsgLekwCgRB10NmT8lCgIphCeSTwZs/+2YsfGyYcMgmO497tmxHRUVLy6BLXYDAgnvmRN843Ly8t0RmMV65eVrup8/JzT548cef2zSaNm4x66WVdXe03X26sra4KDA5291DDGVvJzK9cCDU4UBuZJtMGFavVam+kpB4+eHjjhrXz5s48efp0VWVFdFRU3/79hz/7TPLlSx06dZQrZH4BQSo3V5W7B7aF/oNnhxPE3uw2e11NbV1NjZ+/HzwsUcZkWiXSRfIPhSMQOp9Ic4HoVboqW7RquWP7dlxyXEKCTCa9eukSCjAgKMhoNMYkNOozYGDffgMzMzPz8nLd3dw0Om12bs6RA3v9/QJHvfySWCBMvnb1eur1M6dP8F0cXXv0SGzWtF2HTgOHDElq0xbpyo6duw4fOrhv/67y8jLIHcZkNpqMvXv2GfLEkwHBQSKUuER2/Vry+DFvnj1zukWLNnkFuXW1tUmt2kLaJiYmPP/CCxKxCKYJCwtTKhUyGXkAzmG3IslBddi+ZbvBaJgxew5WhimhqWivbUOGvflgZcUv+ZPVwHbURIuFMRoMyI3z83MP799/9sSxkuJiF5s9ITGxXafO8YmJnj4+JOuxOQdFPDTtQvlNIGfNJjOalc3ucvN6yuYtWyZOmSIUChcvWnDx0gU4c4axQFa2bd/e01ONHNVqIQ/XElHI4ZBH/fAP0Yg/603AtzA9OyKcjCDOzc6dPXOGyWR8f9GS6NgYnUa7a9uWiIjwsIgIMsU3j4NE/dD+A62S2rh5eJAbBwDe6ldvIPwCrUazY+uW+MRGPn7+2BARhAzXeHjDnP7QyVAolIfF30MEI+C5qlxv3Ui1MgyCGWIY6zDI08dwrO06dmrbofOI0S/l5uelXE9unNCoZ/eec+fN/uG771ontRoxanRNZeXi9xe9v3Dhwb17rly8eOPatZRrVy+cPXP71o0TR46s+PTTDxYuXP/5+sOHD6ZlpMMLt22V5OXpER4W2qFDh4rS4h59+5oNOoNBL5Urg0LDyFRKrHQWsrM+kZDscEBhB4WEQo6xTvlhPjXcIOGQfvX6AdwOK3lyxl5VUX744IH4+ASVm/vJ48e2bd3WqlUrJAxYGcWSmZF+4vjxAf0HQZ4qFK7du/e+lnz19KnjZqN5ynvTvT28L18652K3J7Vu3a5TF6NeLxSSyc4cHF5S2/b3MzNTb97QkvdluDg4XLFY2KF9p6kzZ/v6+EEOnz97ZsrECevWrkH5WyzWk6eOWWy2+PjGCFNqtZprs2ZnZXbq2lUsEtRWVyqUCpGIPMOGREWv1XyxZnVycsq4CW8rFApcFcIsjkqDUUMG7Y7H48NWjNms1+kgfGH0S+fObt+y+dypk3qdNiQiql3HDi1at2nWoqVvQICrSiUkU3OgIpBJbaFaUGlh/frdUf562C4Mm0Gvq62t+WDhgtatW7dMagcTnDp1Ojsn24XMtMIpLSnWVddERER4qNV8AY+YiTxT+h9FMKuAkc8QU+bn3P98/frd+/Z/9cXXXXr21NbppTLJ/HmzR41+ISwyggxwctiKi4t379zVvnNnNzcVzoeI6D/YSQHH9c3XX7Xv0JEVwaQWcR/eJMGAimAK5ZHQIIZD2Ml72cik9AadViKVQWJCAFktVujOy+fOte3YSSaXGHR1RXmFlZVVCc2aSWVyg8EklcksVhvDWIQiocHIbFi7buPna9Vu7uSFyBZrcXGRUqmEs+QLhK3btOk3YIiXl7dQLLp9KzX93r2S4hLGwtTWaTgOm59vQNb9jKKiApvNKhaJxr81jsvlLf/k4wH9B/h6eT3/0stQTlwOly9E4CSzASGUsiN9OTjnjHv3sFVEdAxfwNfr9NBSCNHsNf3MZf/DQFhCyWvq6oRCoVgi0RPNKjTo9R9+8EFwcNCzI5+H3nh/9syOXbv1HzTYYCAjvBEyoJXFElFlRcX9jMx1a1dDOe/eu0fA44WEhs2YNTehcZPlSxZ9/8O3CC++/gFtWiUh2MQmNIFxTSZGwHcpL6+6kXzVxz/IbrOWlxWXlZUWFhUajUa5VJbUul1G2t2U1GQUfqOExGeeHREWEb5/z677GWnhIUHPv/BifOPGCDGIlwadDkGRYUzQ2DdSUmbOmPXDtq0qlTus6uwGRiii0aghU1VZcTMl9d6dO2az2d/fLyQkzNPXRyKVyOUKuA5UAOcQiZ+66OBbfi53yOhVauG/DnhvmEYsFrPjFMj7VuCBzWYrROS9e3d2bNk8dcZsd7X68oWLH36w8FpKikIuR5MsLStnGLOfn39wUKBcKlG7q1sltfYPDvXw8oyKihLwBQ47GUphJ7fubAIBH5kPDI0QoNPptm/dOmvmDJlMtv/QUS9vb5lMcjv1Rp++va9dvy6TSiVSKZxP2p2b706atGzFqtCwMEhsuwupIT/66t9FSXHxxPHjZs+eExAcLFcozWaT1WJ5iONqcJL1SxQK5X9IQxHBcElwgjaLtbqq8uK5c4OfGmaxWOBGU69du3P75qtj3yCz9VvIq79IXx2XzHFmNJltdheJRILNGav98oVLyz9ecj3l+uatOzesX8WYrZcunsPKY8dOOH7iKGMyicRSmUJeUlwANQYFXFdXW1NXJ2CfwHNVKPQG3aA+vWx2e5OmzWLiYgUi8cZ1aya8M0Xt6SmVyjS1tdDlZBLZB9Qt1JKmtg6npXJXQxmaDAaRRPJT9P0HAxGM3EOr1ZK0QSIRiyU2uw15wonDh7Zv3Tz+nSlh4RHffPll8rXk9xcv9vD0tFitkB1GvdHBcSnMzf3mi41KV9WOPXvSs7L8fH0rqirDQ0KLiov79u2flNT21q3Ug/v34kOj0QRzIIYiaKGOkOErVhuXTwKh1WZxV7lFRcaYrZbc3BwEJLXKTSQS6vT6YU897efnK+TxBj75RNbd21KpOKFxY7FEipCJkCwQiixmE3aSk3V//pzZH3/6qYeXV/1VsTwO5vtbY2JftQD5AjhkSm+rWPpYNLq/EXDIOq0W7U0mVwiEwro6LWOxiESicydPhkVEeHp7c7i8lR9/pNFo/AIDu3bv4R8cknM/Z+f2bZs2fVdaVhoXG//hR8uQCRv02oL8vNzc3PvpaQqlokevXi1aJkEK22z2spISN7UaCfON1Osvvfgi0pw5c+cMfOJJeCGBQLB90/fr167Zse8gh8tBk4ejzs3MmDhu7MefrYyIjID6RdTDh3+o2hQXF497/bW5CxaEhIXjusjoc4cdyX/9138aKoIplEdCgxgO4SB3vMgQW7vDYTaZ8nNyQiLCkeULRSKlUnErNTUqJkYkFvP4Qj4fCphntTmKC4uUKnfGzBw9dPiLDes2rF97+vhhPpcXFBBw4/o1F3hhTR2XPLZlzsrMKCwsqNPURsfE3b19Q6V0LcjP53E4fB7PaDTERscOeuKJ68lXhw97RiqTKBRySKgmLVv5BwQ2b9nK1U3FYe/AcnnQylIouV90IUECisTOufrJnEHwqo9HPyKukcymtPrT5fl5+WFhYSKRGKXk5x9gMuijY+MUriohXwBBHBAUFBwShjKBAIUFUUIKhWvbjh34AmFpSQnM3q1rj25du4eEhgX6BwYEBu7bvfPi5YsoxoDAoKDAALFIZGRMCoUsODAEhsNB3VSuMmII0iVfUlZaUFRoc9iDA4Owh4GDhhTm51+6dL5vnz6wqYDHjYyJ8fHzkUhl5A2vFqtQLMJWqGBVVVXvTpo0YtSokNBQWLD+mlgeD/P9jYEHQNLF5wvYoTEcmI+arEFRVlq68/vvLp8/dyP5+t3bNzPS02tqaouLitZ89olcLmvdvr1zjnYknw67/eatmyqFEl4iKCSkU5cuzz73XOtWbUqLi9avW5OTldmocePGTZsnNm7cb+DA8IiIkpLi7775aveOHXKpNDouFk754L69HyycFxwU9OmK1e06dhSLxXqdDr5o186dvXr2iktsROZ4YUcuoNXv27u3U6fO3kSCk7sB8Nh/qOLU1dVt+uGH7l27+QUGsf7nYSpgQKsxhfJIaBA9wQ67w2azcnl8o0GPqJadlZV+927Hrt0UcnlVVeWVSxfVnh6JTZparZDJdjIwQSjG0o7tWzesW5eSet3MMMFBwS2aNYOo8vHxSWrdVu3hGRMT4+6hhujRaLQ1NVXZ97MvnD93Pfka3K7BYICrdXVVQNNarFZ3d3cXLmfajFlZaXeiYqLNJmNgcCgcErx5ZVlJbKNEHAv+DiKPPK7xQE8wHKtQKGLHBNuFIvIqu8ekRwrlbCbvlzVdunB+yaL3P/5sRUxsnIVBxmFGSiASCcktUROzasVnRfl5y1auspAHX8ykT5fHNej1AoHAYDAydu7pk6fzcrO6dO/5+dpVM+YtXDJ/7tMjRr/7zlt309NwjKFPPHXh7On8woLwiKjS0hJsqFAounTqWlxclJZ+z2gmL4jy8fbRG/RJSW0mvD0xM/2e2l29beumrKzMDxZ90K1XLzItkwsZaUPGFwsFWB8nZjKZP16yODoycvDw4UKcys8jGe1T/DuAnIpUPySd0D1kiCelwQB9aScTOpBXaQAYy2qzZ6VnjHnz9U8+W4XcVuGq2L9nz4zp01VKRdNmzXv16dO7X38uj8eYLXq9HukNn8/T1NXevX0rIz0tLy+Px+cjSsH9+vr7efn6V5SXbv7+B+w5PCysvLJi2vQZiU2b2Kw2oRgumo84gv9eHPHshq+/dY5VwCdIuStKS1576cX3Zs5q1qI5maiRfbLNecK/AgIT/sOhsYwzee7pZ1Z89mmTFi3IQchUwez8xw8J2hNMoTwSGkRPMEnV2YknoTXhVoxG471bN2Pi4pGyK5SuWo3GZGK8/fyRvUvlSigwyOU3Xnlp2fLlufl52Dg2Jn7V6nXDnh7eODExODhIJBBYzaYbKck3b6ZeOnsm7c7tsrJSuVw2cNDgkaNHjxg5qknjxjqDLj3tbnlFeVhoaGxcXKtWrSKjowIDAkQiga9fABx5Ztq9jLt3ouMT3NzVpM+Jw4Vvxhk+mK3z2U/gIp1T7fz8y3825O0DRoNB7eFx7eoVZDAJiYliiVQqlcGOUCdE6QpFPIcj9caNli2TYETGzCAmkvfnsVbGJw4ut6SktLKqEgo4NeV6zv2s1NTrVy6ev3HnZuOERKVC4R8YnJeb68JxeX7ki/fvZ9XW1rgqlW+8NfHOnVs5ebkjnn3e1VXpqlSMGfNWRtrd4oKCF156JalNUmJ8HKPT+fn7BAYG4EACPnmNBRuueFYyg4Dp0L69JqPxmZEjIZ4kOGG28/4n6q+P0rCB1WBT8oAsNVkDAxZxNinYCK6RyEQO97PlH3fp2rVjl65Ckej86VO3bt4sKS4aNvzpN8aNj4mNhQ0FAp5QwJNKkdQI+TwOdHBEZGTrtm06de4Cd90iKalV23beXj5ikcDH269Xn97NmjXr1rPna2++GR4ZiXiANg4nDOB8sOfbd273GzjoJ/+MKmLQ6w7s29e8eYuQ0DA7O6Xx76k5FgsiiREaGldTWV6+ffuOvr17qT09cSw4fXJpD4/fcz4UCuWh0xBnh0AGX1hYKBDwFUolvJVSqTywf19S244u5AYW5/btu9Pfmbhz727y8gUeD0Jn+NMj+w8c6Kl29/T09PXzCwoJDg0PTWjUqEmTpklt2rZq3do/wL+upib52tVzp07cTLmODL9F8+bNmzUXi0X30tOeHzW6dbt2EgkUkUQoFGlqa4sKC2oqK5u2auXp7e3s2CBCl+0PoI6KheQhJrPRVeXm6+195PChpi1aqFRuCEXIHxAhRGIxBIqnt8+Fs2dysu+3aJVEutL5MJagtLho6w/fL1n0/vvz537++Tq9RjP82We9vLz37N0NCwx79jkvD6+a6uqKqqobN1IZxoSoCMNFREbLZXIvT8/8vJzBQ4fdSE2Oj09YuXZdTVXFtcuXx01428tDjTzH189b5e7WuWuXmLgYSCS73c5YLFDnMJ+FYaxWi8PFBau1bd9ezk4Xqq2r+8VwCAqF8nC5lZJy8viJF155DQ38dur1119/PSwsrGuX7m3at/fzD4BLFYtEXI6dQ94Rx/5wOfAeRGE67FCbCqUCToDPF6o9PfyQ2gYF+Pj5RURFQ4zabS42q3OiHoHJbIKLNpnNzz315Jtjx4aFRzwoK21W68njx2OiIn39/fls7vQ7NCcR0FDSiDLI6rMyM1JTkgcPfYIMdGb3gMjwe/byO3mIu6JQKL+fhiiCnRn26ZMnmrVowXYs8I4dPWo0GEPDI0xm5u2xb5w8e8ZsNnO4XLi2xomN3521wNfHQ0DmVnfh8bhQzyJ28jLnHTl8CIEbGBwSGxeX1K4dBJDdZtuzY8e1a1fxSU5ODrxbj1694Ncg4EwmY0lRgV6ri0lo5KpSWRgzl+g98n4NeEOcFXVULByLBWXDiMUSL2+fPbt2YCEsItxgMCCv0Ot0d2+kKhRKgVBoMBq+//abFi1aePn4mIzGE0ePLJg3d93nnyP3MJktUVExUrksMz397p3bxSXFCHUwjX9AUKfO3YY981yfPn27duvlsNmMZlNlZTlWiG/UGCb19PQaMHBIm/Yd3dzdGzVq1LhJ0+DQ4NjYWD9/P4RMh5Xhk/mwLFnpaQf27HFzU6vc3BDMcNJCkQj1wVXlKpHLHTYrLIvwxhfQ2bIolL+QWdOnxbMNFd71wO7dDoctOycnLjYWTsPNTYUmiAT5wRnQ0EjJ06vE8fPIHzYrEcY8voMM3sPf+MBmNpmxJnunhw/16GAfrdZpNGdPnrhw/vy7M2Y5la5zhwAR4WZqSkxMbEBQEPwSiQss9V//O0gKzTAcSGE+z2axlhUXF+TnDX7iKZwgggU8Fc5BIHyIL8ugsYVCeQQ0xHFIjNkM4eLl6VlXS95G63A4WrdtN3Xau/v27Jk3a/bFK5clYqlYIoXQUcgkA/v1CvV3FXAYAZ8rgALmk9tU8IpYEImEYokImhg+SyDgSSQi9g4qv1Wbtks++WzNxq9kMmV6esbV5OvJyalWm0NTW3P5zBmdpq5RkyZikRC7geskN76wQJwd6aWoP0WKwwUyl2HM8N1NmzY7sG9vfk6OXC63OxCZhLv37v18zUqRkBcSEsZYbPey8spqdLPnLBwx+oWjp8+YGRtfIIwKD93y3dfbNm8+evTIsWNH7mfdv3Tx/EcfLenctkXh/TtfrVn+0cLZyxbP5dgtUye/8/68+W+98WZJQV5Gxl2Fq7J7755x8XFKhdTbxyuxaWMfHx+lSoVgarHarQ6ezmi5eTPt66++8wsKCwoLs1ittbW1X33x+dqVnyFkSuVyoVAklkr5QoFYQl6STKFQHhZ28no4MhS4troG3vtmSkpVVeWQJ4aKhXxXpSwsPAQutaaqsra6MjomSuWugotl9R9+EIzYWYEheMmLx/nkOWSSqTrHCXOFfK5IwIMrlohFCoVMKhGz3p4Dh8/nc7GC2WT8+quvtu3eDc/P47ogDPzrh92Nq0qF3VstFi58+m+JTqyAcAEFjAAklkoC4UlsdiTSjMlE3u7BMNR7UCj/ABqiCIZolSuUUqnsyMGDyPElEmnzVklwnaNHP//FVxvbtumAD01Go0AgHNC//8hRzwt5DueDvmQYGqQrfB5xnv/ycfgSP85viHyDe+NyM9PTP9+wDk5N7ea+bevmo4cOvvXGa/fu3U1s0gzrkPFkKB2yJ6J9nQvOvVEAYgPK0G61olyat2yZk51dWVVFxoywgzXbt21z8/adO7duBwaH9OjTb+b0d/t2775u3WqtVkuyGtLZz2udlBQUGoJiRjxydVV4e3m4qVSB/n49eveeOW/e95u3nLlw4fTZcyNHPpd89QrE8b49O2NiogcOGLzik6UDenU/cfSQzUZmXiOmYcGZmM0M4uXVS5cWLZzfoWv3bj172Ww2XW3tpu++PXbkWJ++/VG1cPJsffiNEEihUP4LHC7kNRYQwkgyoTsP7Nk1sH8/lZtKKELuKUJrFctkn3/xxXMjn1er1TVVFUik7XYyPxDcAn6jdbKOnNzXYx2u8xN4jB9/OA7O//txcTjsFktJcbHazc3b28diMpK+XufgCvaHzCdvNiM6CPgC7N1qtTl3+ysQn8KObnb+iW0tDKPT1PHIY7YQ4hIeTpJCofzNaYgiGH5HIBDEJCQU5OYW5hfAv5mMptZJbeBJ16z/2sfHz87OD6pUKgYPHurp7a2pq/0th/ZLoI2uXbl8Nz0tNjY+Jjbuyy83vjX2zS7derz46mtarcZhJ0K5flXKf0YoEsNYjRKbNG7a9PDBAzU1NfjQarU0bt7SzJh27dqj1xtlUoVGW5eWccfusHN5pFceStnH22vgkKEisZg8wY0IyCYmMCIZVUzeakHiDBnDwHHp1K3b9Fmz9uw/uHLthqqqqrUb1ur0ujt373z80ZK0O3edp+EEe0BV2fL993t271ny8SfdevTCR1bGcuLE8Zs3Uhe8/75cLkdorF+bQqH8BUAsQiOScbQ6ndViGTT0iUFPDuPz+WKxBM28cYuWQf7+Gffuomkb9HqhQOiwIpm11G/83+PQGwzzZ88eP3GSpqYafgmnUf8Ni0ZTp9dq4HBwSs6xEPVf/G6wQzgubV2dRCqFY4FANxoN9d9RKJS/LQ1RBNvtZCJJH1+/qNjYsvJym80uEokCAoPefHN8VEz8nn27ystKhSJR7569W7Vtq6mtdffw4pFXuP0GZDAZ9sX+mIzGe/fuioXC9h07hYRGRkREbNj4xRNPPsUwZqXSlTGZykpKDHpd/ZaUn+NwOCwMQ9SqgIyWlsplPXv2TL93r6K0lDGb7Ta7i4PTrn3nDxYvbp3UYu68GXUaDZfLs0GAOhwwAWTw4IGD2rRtazGb+Twe7AIQlZzDrzkcLqKi2WTSabUymYzH5UmlcqFY3KRZ8x+27bibcd/X28dqYWC+I4cPwo7YFudjs1oRU9evXXf1yuV333svICAIp2c2m/fu2nn48KHJU6f5Bwa6eag5Pw+NFArl4QJ9aTab9Dqd2sODMZsioqMVrq7s1M58tO7g0NBRr7wSHBamJK+zFsgUCngP5+MWfwaLxbLpm6+7d+8WFhHh6q6GRyDpNLJr4qzwLaPRaKRSKeII+Zz0DSMc/LG5QaHs/X39DAYD3BQiiMNePy6ZQqH8rWmImoDH48FbcbmcwKDAYwf3O1wc5eVle/bu7tWnf2bavaqaajhaLw+Pnr37qdUeak9PkYhMYVO/8X+AneTBBqVFboRxXIqLCm/cvNmpU+eevfv4BQe2b9exSdOWQrFEKpMZjIabqdfFIgH+qN+Y8nMQ50hfC4c8u0KmRePyWrdr73DhXLp4Hl9xuVxEOE8fPw6Pp9VpSaggfbRkSAksi/ATGhjYq2cPhVIhkkiI6v3xlQfsQD3no40CfKJ0VWHPzs+hhlnBbTt64GBdXV2jhEbt23XYsXXL1QsXKysqNbWagvy8qRPf1mtq3hr/tlyhQL2GUN783benT554661xAcHBiIvOvdVfA4VC+WtA45XJZWja0LhCkYiM6BWQZk4G9nK5fgEBzVslwdPiW8hfLnzCn05Nnf27I0a/iKyY/I0s3Wxm38HERZIMj1VbWxcYHIJ4IZXL8TliATwSu+nvBV6leatWKddTsEOSz3O4Kne3+u8oFMrflobZMeaAW4SLik1IrNZobiZfWzh/bqNGidFx0ZCy8KjwbT179enep09NVZXRaGQYxsr8RlJOhqLa7TzytjmrpqZm/+6dddXVw595LjAkVKWU+/r6SmQQvVKDXr932zaZXOHqrkauX78x5bdQe3iGh4efOnmyurLSZiMzycOCpDvfx1csk7ODEMiYBxQ+pHB8XFzHLp3stj92DxQx69rlizNnTMvJzeHz+GFhkcVlZXyREIH18IF9E8aOiYqOfvXNsR6enmKxBIHq8IEDRw8dfP7Fl2ITEiwMA21tMOjr90WhUP5BQFK/Mnasq5ubXKnAn+T1ouwMiew9KzM0ePrdOyo3lUgitlktdpuNy+M7Z4z5/QiFQh//gDt3b1ssDBwcIpGNDCymUCh/bxqmCCYdh0aDgcvlqJSKkSOey8rMmDp9Vk7m/QWzp1ksVnyu15HxWHwRlKsccpkn+I03WPIFArJPo5HL4aZeT/7m66+lcnlEVIzFzFis1pz7WXBtyZcvLp43VySVJjRpoq3T/LGOgscbLpfbpVu3zIyMe+n3eHx+ZWXl5h++7917wIgRL1ssZHZeu9XKRdjhctXubgMH9uO42GGI+o1/H4g62Vn3NRoNIpu7Wm02GfV6w9SJbw/q1+ejjz965bXXX33jTYlEKhCJzWbzmePH9+3eNWP23NZt20GUw/Q4ONKnP9r9Q6FQGj4c9sXsUL0cFw48A2QuhK/JaER753J5JUWF169dbdq8BWM0YV3GwsCZkKz6j4Bdeard+S4uNdU1DCusXehdJQrl70+DEMF2F87Pf/CJC5cvcHB4QSHhxeUVQ4c+5ebuln0/MzsvB0oK/m7r9s3btu7iCcUVlbqyCq2ZcZgZu5mxGU0Mflusdr3ehETd5uBg2WS2mk0Wu4NvMlnMJubo4cMQRlMmTwkNCxELuLqaGgtjyrh145svv4yMiR06bDhjMrm5u//i0QrKT3BcHHyOncf+OCdnQE4SFBLmwuNfvZpSXFz24eIlZqPh9ddfv3snBQkN1iFvXUIYsTvaJLXu0bu3QMBl7fxrYO0HwdYQsyaGiYuNnzZjbmBIGIyYfPOGUCj49NNPu/boAZErlUstjPHwgb2LF7//7KhRMQkJPIFAJpdLZVJYUyAU0uEQFMo/EolUyufzhCKhiLxJmzgbNPaqsjKT0WCz2qQKRUBQkFQh5wvIRGlkFPIfdAXYm5ePb3hUdHVlpcVstrLUf0ehUP62NBSdh7T8px8IHvgckVgiEAiCw0KjoqL7DxwoFgk1dTUearUbedeX3GGzzZv5zvoVK3Jzsk1mprS0TFNXa7Fa+AIBPCDDWCCmDUajQW+02ck7zPjstOqQYgf27NmydVtQcHBcfLyAx6+rrdq7a/u58+dmvTf9iSefem70aGwEP8qYTVQw/SfYciEPl/z045SYSoXrujWrP1i44MjhQ6NefCUvL/vC+TNc0v/LhaC12azubqoePXoplK5OUcvu7PdiYZgrly9ZLEzr1m0SmjTSaevwYc9uXT9dubpx02ZcHtdqtcBqp0+e3Lljx6q169p16GAy0vEPFMrjCHyOSCKWuyrhbVavXBEbHfPnH78TS6X+AQE/fPeNyl1ts1pEIjpPMIXyt6chdnaSPj92FhuNpu7cyVNj33w9Mibmzq2bZr1eLhGHhoQcOXZ6/FtvSyWS2XOm9+/b4+khAzZ99cVnH304fNCgAT27r/hoaWlxsYvDJsUaUrHRaDIajVaLzWaxJV+9vOiD94Ui4dsTJwYGB2u1mpqqmtLS0k4dO27euatF6zYSqcxV5YYVuHwB5w/er3+cEUvEmppaKNTSstLvvv+uR4+eSa3btGjZOigkxGplR2OTFztxExs36dmnH9Y36vScP1j3zGZzyvVrUNSdOnc1GsypqckD+vT6aNnymPg4oUhkIb0ynJPHj6/69JOJU6Z4eHvjcFIZGSBIoVAeNxBE+HwB4khxUWFddVWrtm3/vAi22WwJiYlane5+RgYdVkWh/DNokDrP4TCbTBbGfPfWzYqqymHPPm+z2n39AgKDgg4dO/nWmLHx0eGz5s5LuXVvw7rPWzZrUVJWnlNY1KlHr007d+89cmz4yOc1dXUfvv/+nGnTzpw4YWMYdmCD40Zqyvvz53t5eX3yyWdde/TiC/gSibioqBB7XvjBhyKxVK6Q2+12xmw26PVWiwWb1J8P5bdAsBGKxRqNBsstW7QcO/5tH1+fyJjIpk2aIaMRCkVWhpFIpQlx8WpPD5PJLJG7IkpZGAZFbSFFXQ/Kn/2XgwoAI7pwXLCAlAjh59jRI/lFhaEhYc1atoKu5vJ4Tz070j8wyGgw6vV6u9W66ZuvNn/37bvT34uPT3BVKHk8ntnMPipOoVAeM6wWhjwMYLen3bvXvmMntdqj/ov/Frgmo0Evlco6tOuwd8+e2uqaH50VhUL5G9MQRTCHyxWJhNXV1Z+vW9utRw+jyejC4RQXF707ddKzTwzct3OLjTHKpDwXq3n4s89s2r7j+Kkz/QcO3rll09D+fd94+aWTRw/LFcoJk6e+M326Xqcf+9rLi+fNW/vZp7Pee3fU6NErV61p26ED6784Eonk3p1bHdu38/L2Egr5DocLl8sRCAVSmUwildSfDeV3wOFwIDpRqnK5vFu3HmoPb61Wf+zQ4RPHj3E5PJPJwM5VZDMhjOj1zmnzGcYKS0ukMh6Pb7PakHug/MmAbqsNexOKxHKFwmqx8vh8vV5XXFCwYO4cL7XHmrUb3dzVu7d8JxKJ4hs1JjO1kdEWnKrKyrrq6jffGteucxecDeoMO0JDVH9+FArlcYLD5XFcHPAhJ48cjo2PF0vJJIz13/1XYHOxiLzcp1W7doxRj51ZH8I7PigUyiOGA2lSv/josJPpIOqXgYOdGuLiuXPffvfd2vXrIWUK84umvzOhrq5218GDRm2dwlWJlYwGo4Mj4AnF0FvYys1NDt1jtdrMJkYoEuzdujU3J7uyojwkPKKqsgIubMQLL/IEQk8vT61G6+buhjUryss2rl03ZvzbSpUSHpO8IpO8CYjyG7DBhGQR+AeJgwO1yOFy4ujxN954pVmTZstWrFK6qW8kX3vz1VfSsjJsdruPn9/LL71RUlq8+bsvmycm+nh49O7dq1ufPmKJmM8XSKVSoVhss1mrKipgVqvNKhKJ3dzdXTi8mupqLFjtjvcXzF+yZMmTTw5f9tlner3ljdde9PPxnj1vvlIhEYvJ26FQjZ1zgkKLazV17JtNBWajQa4kliXnS6FQHiPIOzsunDh58uzpyVOnwR+IJX+qX8Nus+m0OqlMVlZacvnSZYvRMGzEiD8/w/FP0NF3FMojoSE2PIjgutqa7du3TpnyjsNhP3r4wIB+vTr36Nm5a1ezQW+1mF3IC8LMMoVMLBE5HDa5nEwAYDSYIIt5PC4+NOj03fv1e+PtifM++njUq6+9OfGdidPe8/DyUrm6MmaLUCg0Gk04yoVz58xmI5cLMed48KY85Y9itVizszIddsfIF1+SK11dHPbcvPz7eTlQpb4+vs0TG0dFhs+cPfv99xfnFhYePnlq684dH3/88XvvzXjm6Wc6tG0zsE/vWe9N37dnT12dxtvXX6lyg6rW1tW5urlVV1cf2rP3i883yGWyju076LTGlOSLKdevtu/YFRpaKEIFcJhMRouFzNyJZZyMWCxxIKXh8WQKpfP0KBTKYwX8uUGn+/KrL58Y+iQ8AxxF/Rf/LdC7MoUcCwqlsnGTxpcuX6qrrXV+RaFQ/r40CBHMdXHwOP/64XM5F8+e4VitQUFBFWWlZ48fj4sITb+VIuRxK8rLRRI5hycSiOQO8gIyrljEFws5YiFXIRfLpCJsLuC5uLkpVK5yqUQk5HMkIr6bqxyrScQiiUQkEQtkMolMIspOu7tryw/de/bE+gZtHZ+8rox2Gf5eyGQPdhtUJ5bNJrPVartw6ULbNu3i4+KFAkF1jebY8ROM1SoQCgxaTeeOHQcP7u+tVjw/6vkd23dPnDhJb2Ru3r4bHhH16ZoNxy9c/XTdl2079Kyo1j3//KgmTZqOGTP2wvkrFgdXazAf2HforQlvQeOuXLlu8LBhSlfFndu3q6urVq/8eMaUSTt/+M6o0/A4sLLQbrWi5qACiEUCmVTC57pwOQ7aDUyh/OMxm0xajYbcC7LZdRoNeaWb1XLi2LH4+NiQiHCBQMgwjMuDdxv/OKSnBDm93cblcAMCg6Iioz5Y9D5jNuu1OvIWUhcOY2bqV6VQKH8fGmJPcGVZ6c3r18dNnCQUCN3d3AMD/PIKizZt2xEeFe3t62cinbj1awL4Jg6Zqrb+zwd58EPHj7POYoH0IzPmjIx0hUrVsmULmVxO3srL/2MvEHq8Ib2uPB7fyjAQw1C9qdeuFBUWDXv6aU9v7/R76bOnT92y+VseX4h1GiU2Cg4MSLl0wWIyyWXi2EZxYydO2nv46MpVa3Kzc/r16h4XGf7CiGfSb99s06799j37li375NrlK716devWuX3ThNh58+fERkVPnTq9e6+eDpsNGvfo4QNWi/XOnTswWLMWLaQymc1iQZCzmM0IU87z+3fVgUKh/DMRicVKVxW5EcRxkcjkPD7faDBevnD+xdffFIslHB5XKBT9+yDx++FwBEIhj8waRBZat2sn5fHT7t612u0mg6GyvIy+YZRC+TvSIMYE/4Lka9e2b93y3szZcGoGnfbooUNmhhk09AkoL6gvpUpVmJcXGhkJZ1S/we8FF2u3kdlkzRqN5ot169q2b9ehSzeGgXhyCEUiuM76FSm/jsOu02rkSqVRb5RIZbm5eTOmT1d7eM6aO18ilxUVFL019s1Tp0+hsJ8e9syHS5fJpAKhAKXLY6eX57tweYgobFpiMxrMMAsE9JXz5/Lz88urKhnGqtVq1e5u8fHxTZo1i4yKEYtEfIEAMpfL5a5d8dlHy5YKuNx3Jk8dPHSIj5cHDMdYGB6Xh/0hOGGd+pOkUCiPB3DsZqMJAUEslcE9VZaXf7jo/Tbt2vXo3VskksDDSyRSDhn29t+DQ0Ds8gQCm9UmlkjgZ86fPbNv+/YJU6YoVW7wZRKZ7M/IbDommEJ5JDREEazX6epqa93c1Tab7ca1qwadPjU1pUPHDoktWkqkUq1GA3/n6eNdv/bvAy7MarWxU0WSmbmOHTlSVlIyaMhQ9l3zHCLQyHAI2oH4u0AxORw2qFI4boFQvH3zlg8WL/5w+SeNGjW22uzbNm9+9913rHZHXEzsjJmzunXvyhi07moV203L4fAEdgcXqznISGILdiUSiyGOjXqdwtmX40Je9YSvLWYLjMJYLAIBNLDAwljvZ6YPH/Zk48TE+QsXefn4CIXQ1sSgiEAcLjUfhfL4otNoFa6uOq1WJBJ9/83XfAF/8BNPCvh8Lo9vs1kFAuGfdw8Ou8OppLGAfVos1tWfLjebTBOnvWfQ6URikVQGCf5fQkUwhfJIaIgND67E29dXIpUg4Y5v3DgyNqZj585SuYIxm+EpFEpXD2+v+lV/Nzwe2xNpYUxGY/Lly/t374pLSBBLxFx8LuBDQNlt9GbWH8Bmt6FAuVxuXU3N5s2bnhw2LCYmXigU2azMrRvXY6Nj3nh9bPu27UJDQ8QigVwutZoNPB4HP1yOg8d1CPk8EZ8nl4plUjGP6yIW8t3cVHyuC5/HEfC4sIeAx5FJhRKxQCIUQG9jKxeH9cyZk2qlYtacOX4BflKpWCQUILBB+8KIVAFTKI8tNhsZEqXV1MHDZ9y7e+Hs2YGDhwjJ6AXio0QiMfv085/lp75kLJC8XCh4+fU3qyqrDh3YL1cq8InzWwqF8jeiIYpgCBpnWszncVXu6pDwiGZJSaERkQ6HQ6/V2G3k3WDONf8Q2CdfIJRKZW5qj779+zdt3kIqk0P7MiYzfOhDnOzmHw8MYTaZkD4ggbh07ixyiSFDh7qr3XQ67edr1u7esze/oGD3rm0+vr5+fv52KwMVKxKLsJmLi93FYeeQvl47+XEhP1z29y+WsaDX1NhtFr2+1kEeRnGpKi85emD/gkXve3t5QiXXVlbQd2FQKBSAgAF3xOXySotLprwzaeyECTK5gs8nb6l0OOxW8r7Qv6SPQyKVTnp32t6du7IzMswmc/2nFArl70PDVH4cHpdrtViN7CuPrVC98HF8nlAkFkul8HdQYPUr/m7sdvI4nP3/2rv/GEnr+oDjO79/7d7eHd4Bh6dB7sAfh5I26Q+hReSkpW38GWMsGrFVrrZJ+08ba2pFrLY1rVZpRU1MaiJYsYo10Vhq6y/8hSCITbQBBdrjuGPvuL272dmd2Zlnnn6f2a2ptpZDxB36eb0ybJ7dee6Z54B5nvc+832ep7ghXH9+86aL9v5SWmbaPlbKlUajUQwIrjgx7qSVSq125+gDC/d+565r3vvec/fsSbW7eORI2iWc8fgd6d9rd6n7tKc+9Zd/5dJGrbLS65UrlWycTX5z+a9DKd+bKq7esPb4wenO3Gy5XGrWau1268C9d7/vmnftOuecn7/ggma9mvZrm7duTv/ZJnMCoZXL5blNm+757nf+/E/ffP3HPr7r7LPXjqSkf4ozD0Ypg3/8V8AsPl2s1U7dcfpVb3nLVX/8+ttuuXn9CeCxo3LllVeuT06ZcqVcK0aDFp9npc1NrV5I06VyOf1wfaaTVioVCywWVa3ObZqvN+rVaiUtqvgkfXJT5fX5ODnLveVWZ/aLX/jC7bd87eWveOXOnTs7nfY9d337Ix+8rlou/c6+ffuuuOK007bNzs3OzW+u1BozperkUSke6w38EI9xlqdXabQ73RPd5APXfvAFz3vuE888q9nunDjRTf8XpD2QQRAQTp6vTu64Ph7naRM+zrIHjxz5h4/8/cdu+OgbrvqTSiVtGtIuYn0fsbbNT4+1b3+M8jwfDlfTojfNz+/avftD1147P785vW6q7slajQf9QdqDFfuek5B6fX0K+AmaxhPjmH697lLazxxfXNx/7z1PfcZ5g36/1ekMV4cHDxzY+rhTOp3ZtN8pfsGYKQbz5pOb7D/c/dB4PF46fmJu83yv22222scWF+c3z9dq9WycDVZWavVGrW4QHoSTtgyTz5eq/eXlwWBlYeHwx2+4YcuWLS9+yUu27zhjVFwAc9CZ/dHPUTt5o+Gov7Lcarcr1dqxo0ffffU7UoA//4UvOmPnzuLjslbr5D9gXBsBCPyEiWAetry4SVu/0WhOjl7k42ycNuHD1dXq5IjLaLiaZdnabduKTyHzmVq9XpwQ9zAvVp92MCmj00Rq6LTwtOS080vlXalU146aTBboED7EkrYDvaWltK1ZXu594P1/e/jQoctffcWZu3YfeeDQKdu2H7xv/6mn72g0m8XnSY+mtP1Jm6ZRluXZOC/NZKOsVq1+9667/u66ayuV8mt+9/fmN803Ws31uR+KCIYNIYJ5+PJ8NBpVa/UsbfhHWdoVFJk7CdO0f/rewY/ivk3jcbn4PPJH2b6PsyxFcNHWxbCH9Yae7CqKvU/K62KUjJHc8P9der8v93ppI9DpzBafLOXFLeLu/Ldvv+dv/vr5L3jhMy+8sNloDIfDRqu12u83253V1UFtstFY//OPjrRxS1/T1m3t27Sax44ebRf3Xare/OUvve8973npZS971iWX9E6caLbaKcrHk1v5pM3h2tw/QATDhhDBAEyzySc/qTrz8XCwWms0/v2ee9599Ttf9ZrXnHnWrvSbcJ6NqvX62qwbKIXsynKv3mj0ut0jCwtXv/1tL7v8lXvOO6/RaC4efbAYJDY5xWV97u8ngmFDeOMBML3G2ai/sjLo90ulUrPdPnT//W97659deNGzH79z52BleXXQ7y0vr8+6oVKlp5ZNqd5stWfnNr34pb9+zdXv/NYddxxfXGy12o/SZdqAR0IEAzC9SuVyrVbNJycALHW7//ypT+7atevZlzwn/aDRbNYbyckOvX1U5VlWrGc+Llcqm7du+dnzz3/2JZfc9PnPlSvlVMCTyxMZvgXTRQQDML2y0Sj1b7VWSyk5Gg4fOHzk8ldf0Wy1Wp322gkD9cbGj4VIypNL4tRqtUqlXKvX8/H41573/LvvuffgfQeajcbkWsVO5IXpIoIBmF7VasrKye3fxvntt902NzvbmZ1df26KFTco7cz+wgXn33HHN1aLi+fURqPR+nPAdBDBAEyvyRUhiuvMVKvVeqPR2TSfJtafm2bFWo/3/NRPj7Ks0SwuKPnDzooDNor3JADTazgcjsepKPNji0cP3be/1VoPyv9ufdZpMhnEnNeqte6xxYMH7ptJK+0SEDBlvCcBmF6pcdeqN33JRqPv3S5nyqWVTKuaZaN8nFcqxWlx608AU8PbEoDplfoxRW96tDud9uxsb6m7dqOKKZfneSr3Y4uLtWZjfsvWvLiA2vpTwJQQwQBMsVIpVW82ylJEzs7N9ZaWRsPhZMBtYX2embw0GX6QvqYn0pc0UfwkH+d5VvzkkcuLxaalpwVOXiXLs2Ji8vNxMTEJ37V5J2sxHo1GxxcXG41GpVJJ0w/zzvHAo04EAzC9SqViOMRwOCyXK3vOffrCwfsXHlhYfPBoemY0HA0Hg0F/ebCylI2Gxc3Ws+HSiWMPHjq4OljJslHq0EmdPuIIzvPR6qC/sjRY6Q1XB73usd6J46XyTHHRtvRtr7vUPT6Zq1jbtGJpYpyNB/3+9ddfv2fPueVKZXJu3NqygGnhtskATK88z4erq9VarTgMm43/5cZPffC6695w1Zu2n3Z6LanX+yv9f/3mN79z553dbnc0zrZt29ZsNneffc6TztpVqVYH/UGK4Lm5ziMZSZyidlSMZ6gUqzAclsrlXq9395133n/gQPESg3690di54/QznrDzlG3bs1TepVIK49e99g8uuvBZl1x66abNW4r7ZZRLqYbXl/j9nDMHG0IEAzC98nHe7/dr9Vqv2221OylAP/fpGz/y4Q+//BWX/8wzn1muVHu9/q23fv1dV//V52+66cRSr16vDYfDVqOx52lP+43f3Hfpc5+3dcumRu0RHYcdjWeOHe9V6/UUuF/87Oeu+8D7v3rLzYcPH05pm9o6fT3v3HPffNWbztr9pCedffZSt/v1r3z51q/d8oQzz9x76aXtdqfZaqaObzRb6W+zvsTvJ4JhQ4hgAB4z8jxfHQyWl5e/dcc3vnzTTQcPHWq1587c/ZTtp+1otlvHF48duv/AP974yVtvv23x6NE8H+884/H7Xr3vt3573+zcXLVWW+n10hJanfb64n6IQb+/2h/Mbd68dOJ4qzO7cGhhbuspX/nSV6/8o9fdcvutxRWLa/XTTzt9z5Ofsvvsczqzs1k26i4efsbTzz108P79+/dftPfiX33Bi+r1k72VnQiGDSGCAXjMGI/z/spKrV5fu2VGuVwe5zPDLJVtKt68VC4O+J44vrxpU/u+/f/xmU9/+sZ/uvGWr91cmckvu+yyV+27Yvv2U8f5uNVu/9/XLMvzooPTRIrmztzcx2/46Nvf/o677r77tFNPvXjvc/ZevPcXL95bLpWbrUaaJ8vG2WjUaRe3Sj5+bLGZtNrF1dyq//vgh/9JBMOGEMEAPKbkM6uDQSrHeqORTdTqteLEuDyvVKvlcmWwspKeWjxypFytzG/Z2j1+fGFh4UPXXfuJT3zijB07fv+1f/hz51/ww0YmrDl29Ggq2QcPH/7Lv3jrZz772SfufMLr3/jGc5785E6nPRqOmq3WyvJyuVIZDYfpFSuVSlqHpW53dm6u0Wz1V5ZLpVKaOPkRGCIYNoQIBuCxJCVjSt7UsNVqLc/HK71uo9lMJbr+9Ew+Hudr1xYervZL5UpxoYbVYWd20zgb9Xq9aq3eaj1EoRZnwg2HRxYeSAvZsvWURqOeXvHo4Qda7fbc5i2DleVet7dl2+OybFyrFQek07OVWjHwN63daDRaWV6a3TRfq9XWlvaQRDBsCBEMABtJBMOG8MYDACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwSnmer08CAEAMjgQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAwhHBAACEI4IBAAhHBAMAEI4IBgAgHBEMAEA4IhgAgHBEMAAA4YhgAADCEcEAAIQjggEACEcEAwAQjggGACAcEQwAQDgiGACAcEQwAADhiGAAAMIRwQAAhCOCAQAIRwQDABCOCAYAIBwRDABAOCIYAIBwRDAAAOGIYAAAgpmZ+U92BZu5aXBjwAAAAABJRU5ErkJggg==" /></p><p>أ-&nbsp;&nbsp;&nbsp; إذا استعملت ألفاجان بي بأكثر مما ينبغي</p><p>(الشخص الذي يستعمل جرعة مفرطة من ألفاجان بي قد يحدث لديه العَرَض التالي، انخفاض ضغط الدم (نقص ضغط الدم</p><p>تم الإبلاغ عن آثار جانبية خطيرة في الأطفال الذين بلعوا ألفاجان بي على سبيل الخطأ. وقد شملت الأعراض حدوث نعاس، وترهل، وانخفاض درجة حرارة الجسم، وشحوب، وصعوبات في التنفس. إذا أُصيب طفلك بأي من هذه الآثار الجانبية، اتصلي بطبيبك فوراً</p><p>&nbsp;</p><p>ب-&nbsp; إذا نسيت أن تستعمل ألفاجان بي</p><p>إذا نسيت أن تأخذ إحدى الجرعات، ضعها بمجرد أن تتذكرها. ولكن إذا كان موعد الجرعة التالية قد اقترب، لا تضع جرعة إضافية، وإنما خذ جرعتك التالية في موعدها المعتاد</p><p>&nbsp;</p><p>ج-&nbsp;&nbsp; إذا توقفت عن استعمال ألفاجان بي</p><p>لكي يكون ألفاجان بي فعالاً يجب أن يُستعمل يومياً. لا تتوقف عن استعمال ألفاجان&nbsp;بي إلى أن يوصي طبيبك بذلك</p><p>إذا كانت لديك أي أسئلة أخرى بشأن استعمال هذا المستحضر، اسأل طبيبك أو مقدم الرعاية الصحية أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع الأدوية، فإن ألفاجان بي قد يؤدي إلى حدوث آثار جانبية، ولكنها لا تحدث لجميع الأشخاص. إذا كنت تشعر بالقلق، تحدث مع طبيبك أو مع الصيدلي. لا توقف استعمال ألفاجان بي بدون أن تتحدث مع طبيبك</p><p>حيث أن الدراسات الإكلينيكية تُجرَى تحت ظروف شديدة التفاوت، فإن معدلات حدوث التفاعلات المناوئة التي تُشاهَد في الدراسات الإكلينيكية لدواء ما لا يمكن مقارنتها مباشرة بمعدلات الحدوث في الدراسات الإكلينيكية لدواء آخر ولا يمكن أن تُشير إلى معدلات الحدوث المشاهَدة في الممارسة العملية</p><p>قد تُشاهَد الآثار الجانبية التالية في العين أثناء استعمال ألفاجان بي</p><p>الآثار الجانبية الشائعة جداً تشمل: حدوث تفاعل أرجي في العين، اتساع واحمرار الأوعية الدموية في العين، حكة</p><p>&nbsp;</p><p>الآثار الجانبية الشائعة تشمل: حدوث إحساس حارق، أرجية في العين، احمرار السطح الداخلي للعين والجفن، ارتفاع ضغط الدم، تفاعل أرجي في العين، جفاف الفم، خلل في الإبصار، خلل في المذاق، تفاعل أرجي، إجهاد في العينين، التهاب واحمرار وحكة في الجفون، غشاوة في الإبصار، التهاب شُعبي، كتراكتا (عتامة في عدسة العين)، التهاب في العين، نزف في العين، التهاب العين، سعال، دوخة، عُسر هضم، ضيق في التنفس، زيادة الدموع، إفراز من العين، جفاف العين، تهيج العين، ألم في العين، تورم الجفن، احمرار الجلد، تعب، احمرار السطح الداخلي للعين والجفن، الشعور بجسم غريب (الإحساس بوجود شيء في عينك)، اضطراب هضمي، صداع، ارتفاع مستويات الكولسترول في الدم، انخفاض ضغط الدم، عدوى (أساساً نزلات برد وعدوى تنفسية)، صعوبة في النوم، التهاب زاوية العين، اضطراب في الجفن، التهاب الحلق، حساسية للضوء بشكل غير مريح، طفح، حكة، رشح من الأنف أو انسداد الأنف، عدوى في الجيوب الأنفية، التهاب الجيوب الأنفية، الإحساس بالنعاس، لسع، تورم في الطبقة الشفافة التي تغطي سطح العين، إفراز الدموع، ومضات أو طافيات في العين، بُقع أمام العين وصعوبة في الرؤية بوضوح</p><p>&nbsp;</p><p>الآثار الجانبية غير الشائعة تشمل: حدوث خدش أو قطع على سطح القرنية، شُعيرة في العين، جفاف الأنف، وخلل في حاسة التذوق</p><p>&nbsp;</p><p>بعض المرضى قد تحدث لديهم الآثار الجانبية التالية (معدل الحدوث غير معروف): بطء ضربات القلب، اكتئاب، حساسية مفرطة، التهاب القزحية، متلازمة جفاف العين، نقص حجم حدقة العين، غثيان، تفاعلات جلدية (تشمل حدوث احمرار، حكة في الجفن، طفح، توسع الأوعية الدموية)، إغماء، تسرع ضربات القلب. تم الإبلاغ عن صعوبات في التنفس، بطء ضربات القلب، غيبوبة، انخفاض ضغط الدم، انخفاض درجة حرارة الجسم، نقص&nbsp; التوتر العضلي، نعاس مفرط، شحوب، هبوط تنفسي، ورغبة في النوم، في الأطفال الرُضع الذين تلقوا محاليل عينية تحتوي على بريمونيدين تارترات</p><p>إذا حدثت لديك أي آثار جانبية، أخبر طبيبك، أو الصيدلي، أو الممرضة. هذا يشمل أي آثار جانبية ممكنة غير مذكورة في هذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>يُحفَظ ألفاجان بي في درجة حرارة 25&deg;م أو اقل.</p><p>EXP لا تستعمل ألفاجان بي بعد تاريخ انتهاء الصلاحية المذكور على ملصق الزجاجة وعلى العلبة الورقية بعد العلامة &nbsp;</p><p>تاريخ انتهاء الصلاحية يشير إلى آخر يوم في ذلك الشهر</p><p>لا تستعمل ألفاجان بي إذا تغير لون المحلول أو إذا أصبح غائماً</p><p>بمجرد فتح الزجاجة، فإن المحاليل قد تتلوث، مما قد يسبب عدوى في العين. لذلك يجب أن تتخلص من الزجاجة بعد 28 يوماً من فتحها لأول مرة، حتى إذا كان متبقياً بها بعض المحلول. لمساعدتك على تذكُّر ذلك، اكتب تاريخ فتحها في المساحة الخالية على العلبة الورقية.</p><p>لا ينبغي التخلص من الأدوية بإلقائها في مياه الصرف أو في القمامة المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي يتم الاستغناء عنها. هذه الإجراءات ستساعد على حماية البيئة</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp; &nbsp; &nbsp; &nbsp; (&nbsp;المادة الفعالة هي بريمونيدين تارترات 0.15% (1.5 مجم/ ملليلتر</p><p><strong>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong>المكونات الأخرى هي صوديوم كربوكسي ميثيل سيليلوز؛ بورات صوديوم؛ حمض بوريك؛ كلوريد صوديوم؛ كلوريد بوتاسيوم؛ كلوريد كالسيوم؛ كلوريد ماغنسيوم؛ بيورايت<sup>&reg;</sup> 0.005% (0.05 مجم/ ملليلتر) كمادة حافظة؛ ماء منقى؛ وحمض هيدروكلوريك و/أو هيدروكسيد صوديوم لضبط درجة الحموضة</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ألفاجان بي هو قطرة للعين، في شكل محلول رائق لونه أصفر مائل إلى الأخضر، في زجاجة بلاستيكية. يتوافر ألفاجان بي معقماً في زجاجات ذات قطارة من البلاستيك الأبيض المعتم LDPE ولها غطاء أرجواني من البوليستيرين المقاوم للكسر (HIPS) كما يلي: 5 ملليلتر في زجاجة 10 ملليلتر 10 ملليلتر في زجاجة 10 ملليلتر 15 ملليلتر في زجاجة 15 ملليلتر ليس بالضرورة أن تكون جميع أحجام العبوات مطروحة في الأسواق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp; &nbsp;صاحب حق التسويق&nbsp;</strong></p><p>أبفي إنك, 1 ان طريق وكيجان</p><p>نورث شيكاغو, آي إل 60064,</p><p>الولايات المتحدة الأمريكية&nbsp;</p><p>&nbsp;</p><p><strong>الصانع</strong></p><p>ألليرجان سيلز LLC</p><p>واكو، الولايات المتحدة الأمريكية</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت آخر مراجعة لهذه النشرة في يونيو 2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ALPHAGAN® P (Brimonidine tartrate Ophthalmic solution) 0.15%.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is brimonidine tartrate 0.15% (1.5 mg/mL).
• The Other ingredients are sodium carboxymethylcellulose; sodium borate; boric acid; sodium chloride; potassium chloride; calcium chloride; magnesium chloride; PURITE® 0.005% (0.05 mg/mL) as a preservative; purified water; and hydrochloric acid and/or sodium hydroxide to adjust PH. For full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sterile Ophthalmic solution.
In solution, ALPHAGAN® P (brimonidine tartrate ophthalmic solution) has a clear, greenish-yellow color. It has an osmolality of 250-350 mOsmol/kg and a pH of 6.9-7.4.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ALPHAGAN&reg; P is a relatively selective alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The recommended dose is one drop of ALPHAGAN&reg; P in the affected eye(s) three times daily, approximately 8 hours apart. ALPHAGAN&reg; P ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is to be used, the different products should be instilled at least 5 minutes apart.</p><p><strong>Additional information on special populations:</strong></p><p><br /><strong>Renal/hepatic impairment:</strong><br />ALPHAGAN&reg; P has not been studied in patients with hepatic impairment.<br />ALPHAGAN&reg; P has not been studied in patients with renal impairment. The effect of dialysis on brimonidine pharmacokinetics in patients with renal failure is not known.</p><p><br /><strong>Pediatric population:</strong><br />ALPHAGAN&reg; P is contraindicated in children under the age of 2 years (see 4.3 CONTRAINDICATIONS).<br />During postmarketing surveillance, apnea, bradycardia, coma, hypotension, hypothermia, hypotonia, lethargy, pallor, respiratory depression, and somnolence have been reported in infants receiving brimonidine. The safety and effectiveness of brimonidine tartrate have not been studied in children below the age of 2 years.<br />In a well-controlled clinical study conducted in pediatric glaucoma patients (ages 2 to 7 years) the most commonly observed adverse reactions with brimonidine tartrate ophthalmic solution 0.2% dosed three times daily were somnolence (50-83% in patients ages 2 to 6 years) and decreased alertness. In pediatric patients 7 years of age (&gt;20 kg), somnolence appears to occur less frequently (25%). Approximately 16% of patients on brimonidine tartrate ophthalmic solution discontinued from the study due to somnolence.</p><p><br /><strong>Geriatric patients:</strong><br />No overall differences in safety or effectiveness have been observed between elderly and other adult patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4.3.1 Neonates and Infants (under the age of 2 years)
ALPHAGAN® P is contraindicated in neonates and infants (under the age of 2 years).
4.3.2 Hypersensitivity Reactions
ALPHAGAN® P is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.4.1 Potentiation of Vascular Insufficiency</strong><br />ALPHAGAN&reg; P may potentiate syndromes associated with vascular insufficiency.<br />ALPHAGAN&reg; P should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud&rsquo;s phenomenon, orthostatic hypotension, or thromboangiitis obliterans.</p><p><br /><strong>4.4.2 Severe Cardiovascular Disease</strong><br />Although brimonidine tartrate ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease.</p><p><strong>4.4.3 Contamination of Topical Ophthalmic Products After Use</strong><br />There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products. These containers had been inadvertently contaminated by patients who, in most cases, had a concurrent corneal disease or a disruption of the ocular epithelial surface.<br />Patients should be instructed that ocular solutions, if handled improperly or if the tip of the dispensing container contacts the eye or surrounding structures, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent<br />loss of vision may result from using contaminated solutions. Always replace the cap after using. If solution changes color or becomes cloudy, do not use. Do not use the product after the expiration date marked on the bottle.<br />Patients also should be advised that if they have ocular surgery or develop an intercurrent ocular condition (e.g., trauma or infection), they should immediately seek their physician&rsquo;s advice concerning the continued use of the present multidose container.<br />If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.5.1 Antihypertensives/Cardiac Glycosides</strong><br />Because ALPHAGAN&reg; P may reduce pulse and blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with ALPHAGAN&reg; P is advised.</p><p><strong>4.5.2 CNS Depressants</strong><br />Although specific drug interaction studies have not been conducted with ALPHAGAN&reg; P, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or anesthetics) should be considered.</p><p><strong>4.5.3 Tricyclic Antidepressants</strong><br />Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine. It is not known whether the concurrent use of these agents with ALPHAGAN&reg; P in humans can lead to resulting interference with the IOP lowering effect. Caution is advised in patients taking tricyclicantidepressants which can affect the metabolism and uptake of circulating amines.</p><p><strong>4.5.4 Monoamine Oxidase Inhibitors</strong><br />Monoamine oxidase (MAO) inhibitors may theoretically interfere with the metabolism of brimonidine and potentially result in an increased systemic side-effect such as hypotension. Caution is advised in patients taking MAO inhibitors which can affect the metabolism and uptake of circulating amines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B: Teratogenicity studies have been performed in animals.<br />Brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. The highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved AUC exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with ALPHAGAN&reg; P 0.15%,1 drop in both eyes three times daily.<br />There are no adequate and well-controlled studies in pregnant women; however, in animal studies, brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. Because animal reproduction studies are not always predictive of human response, ALPHAGAN&reg; P should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.<br />Nursing Mothers: It is not known whether brimonidine tartrate is excreted in human milk, although in animal studies, brimonidine tartrate has been shown to be excreted in breast milk. Because of the potential for serious adverse reactions from ALPHAGAN&reg; P in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other similar medications, ALPHAGAN&reg; P may cause fatigue and/or drowsiness in some patients. Patients who engage in hazardous activities should be cautioned of the potential for a decrease in mental alertness. Alphagan P may also cause blurred vision or visual disturbance in some patients. The patient should wait until these symptoms have cleared before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), unknown (cannot be estimated from available data).<br />Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.</p><p>Very common adverse reactions occurring in approximately 10-20% of the subjects receiving brimonidine ophthalmic solution (0.1-0.2%) included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse reactions occurring in approximately 5-9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.</p><p>Common adverse reactions occurring in approximately 1-4% of the subjects receiving brimonidine ophthalmic solution (0.1-0.2%) included: abnormal taste, allergic reaction, asthenia, blepharitis, blepharoconjunctivitis, blurred vision, bronchitis, cataract, conjunctival edema, conjunctival hemorrhage, conjunctivitis, cough, dizziness, dyspepsia, dyspnea, epiphora, eye discharge, eye dryness, eye irritation, eye pain, eyelid edema, eyelid erythema,<br />fatigue, flu syndrome, follicular conjunctivitis, foreign body sensation, gastrointestinal disorder, headache, hypercholesterolemia, hypotension, infection (primarily colds and respiratory infections), insomnia, keratitis, lid disorder, pharyngitis, photophobia, rash, rhinitis, sinus infection, sinusitis, somnolence, stinging, superficial punctate keratopathy, tearing, visual field defect, vitreous detachment, vitreous disorder, vitreous floaters, and worsened visual acuity.</p><p>Uncommon adverse reactions were reported in less than 1% of subjects: corneal erosion, hordeolum, nasal dryness, and taste perversion.</p><p>The following reactions have been identified during post marketing use of brimonidine tartrate ophthalmic solutions in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. The reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to brimonidine tartrate ophthalmic solutions, or a combination of these factors, include: bradycardia, depression, hypersensitivity, iritis, keratoconjunctivitis sicca, miosis, nausea, skin reactions (including erythema, eyelid pruritus, rash, and vasodilation), syncope, andtachycardia. Apnea, bradycardia, coma, hypotension, hypothermia, hypotonia, lethargy, pallor, respiratory depression, and somnolence have been reported in infants receiving brimonidine tartrate ophthalmic solutions.</p><p>To reports any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Very limited information exists on accidental ingestion of brimonidine in adults; the only adverse reaction reported to date has been hypotension. Symptoms of brimonidine overdose have been reported in neonates, infants, and children receiving ALPHAGAN&reg; P as part of medical treatment of congenital glaucoma or by accidental oral ingestion. Treatment of an oral overdose includes supportive and symptomatic therapy; a patent airway should be maintained.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Description</strong>:<br />Pharmacotherapeutic group: Sympathomimetics used in ophthalmic &ndash; glaucoma treatment<br />ATC Code is S01EA05<br />Mechanism of Action: ALPHAGAN&reg; P (brimonidine tartrate ophthalmic solution) 0.15%, sterile, is a relatively selective alpha-2 adrenergic receptor agonist (topical intraocular pressure lowering agent) with a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.</p><p>CLINICAL STUDIES:<br />Elevated IOP presents a major risk factor in glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss. Brimonidine tartrate has the action of lowering intraocular pressure with minimal effect on cardiovascular and pulmonary parameters.Clinical studies were conducted to evaluate the safety, efficacy, and acceptability of ALPHAGAN&reg; P (brimonidine tartrate ophthalmic solution) 0.15% compared with ALPHAGAN&reg; administered three times- daily in patients with open-angle glaucoma or ocular hypertension. Those results indicated that ALPHAGAN&reg; P (brimonidine tartrate ophthalmic solution) 0.15% is comparable in IOP lowering effect to ALPHAGAN&reg; (brimonidine tartrate ophthalmic solution) 0.2%, and effectively lowers IOP in patients with open-angle glaucoma or ocular hypertension by approximately 2-6 mmHg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption: After ocular administration of either a 0.1% or 0.2% solution, plasma concentrations peaked within 0.5 to 2.5 hours and declined with a systemic half-life of approximately 2 hours.</p><p>Distribution: The protein binding of brimonidine has not been studied.</p><p>Metabolism: In humans, brimonidine is extensively metabolized by the liver.</p><p>Excretion: Urinary excretion is the major route of elimination of brimonidine and its metabolites. Approximately 87% of an orally-administered radioactive dose of brimonidine was eliminated within 120 hours, with 74% found in the urine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis, Mutagenesis, Impairment of Fertility (Nonclinical Toxicology)<br />No compound-related carcinogenic effects were observed in either mice or rats following a 21-month and 24-month study, respectively. In these studies, dietary administration of brimonidine tartrate at doses up to 2.5 mg/kg/day in mice and 1 mg/kg/day in rats achieved 150 and 120 times or 90 and 80 times, respectively, the plasma Cmax drug concentration in humans treated with one drop of ALPHAGAN&reg; P 0.1% or 0.15% into both eyes 3 times per day, the recommended daily human dose.<br />Brimonidine tartrate was not mutagenic or clastogenic in a series of in vitro and in vivo studies including the Ames bacterial reversion test, chromosomal aberration assay in Chinese Hamster Ovary (CHO) cells, and three in vivo studies in CD-1 mice: a host-mediated assay, cytogenetic study, and dominant lethal assay.<br />Reproduction and fertility studies in rats with brimonidine tartrate demonstrated no adverse effect on male or female fertility at doses which achieve up to approximately 125 and 90 times the systemic exposure following the maximum recommended human ophthalmic dose of ALPHAGAN&reg; P 0.1% or 0.15%, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium carboxymethylcellulose; sodium borate; boric acid; sodium chloride; potassium chloride; calcium chloride; magnesium chloride; PURITE&reg; 0.005% (0.05 mg/mL) as a preservative; purified water; and hydrochloric acid and/or sodium hydroxide to adjust pH.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
It should be used within 28 days after opening the container.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store ALPHAGAN&reg; P at or below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ALPHAGAN&reg; P is supplied sterile, in teal opaque plastic LDPE bottles and tips, with purple high impact polystyrene (HIPS) caps as follows:<br />5 mL in 10 mL bottle<br />10 mL in 10 mL bottle<br />15 mL in 15 mL bottle<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AbbVie Inc.,
1 North Waukegan Road,
North Chicago, IL 60064 USA

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>